40986 Federal Register / Vol. 83, No. 160 / Friday, August 17, 2018 / Rules and Regulations 
the deviation period from 11 a.m. to 2 
p.m. on September 3, 2018. The bridge shall operate in accordance with 33 CFR 117.869 at all other times. Waterway usage on this part of the Columbia River includes vessels ranging from large commercial ships, tug and tow vessels to recreational pleasure craft. 
Vessels able to pass under the bridges 
in the closed-to-navigation positions may do so at any time. Both bridges will be able to open for emergencies, and there is no immediate alternate route for vessels to pass. The Coast Guard will also inform the users of the waterways through our Local and Broadcast Notices to Mariners of the change in operating schedule for the bridge so that vessels can arrange their transits to minimize any impact caused by the temporary deviation. 
In accordance with 33 CFR 117.35(e), 
the drawbridges must return to their regular operating schedule immediately at the end of the effective period of this temporary deviation. This deviation from the operating regulations is authorized under 33 CFR 117.35. 
Dated: August 9, 2018. 
Steven M. Fischer, 
Bridge Administrator, Thirteenth Coast Guard 
District. 
[FR Doc. 2018–17801 Filed 8–16–18; 8:45 am] 
BILLING CODE 9110–04–P 
DEPARTMENT OF HOMELAND 
SECURITY 
Coast Guard 
33 CFR Part 117 
[Docket No. USCG–2018–0676] 
Drawbridge Operation Regulation; 
Willamette River at Portland, OR 
AGENCY : Coast Guard, DHS. 
ACTION : Notice of deviation from 
drawbridge regulation; modification. 
SUMMARY : The Coast Guard has modified 
a temporary deviation from the operating schedule that governs the Hawthorne Bridge crosses the Willamette River, mile 13.1, at Portland, OR. The deviation is necessary to accommodate a filming event for a movie. This modified deviation changes the period the bridge is authorized to remain in the closed-to-navigation position. 
DATES : This modified deviation is 
effective from 6 p.m. on September 8, 2018, to 12:01 a.m. on September 9, 2018. 
ADDRESSES : The docket for this 
deviation, USCG–2018–0676 is available at http://www.regulations.gov. Type the 
docket number in the ‘‘SEARCH’’ box and click ‘‘SEARCH.’’ Click on Open Docket Folder on the line associated with this deviation. 
FOR FURTHER INFORMATION CONTACT : If 
you have questions on this modification, call or email Mr. Steven Fischer, Bridge Administrator, Thirteenth Coast Guard District; telephone 206–220–7282, email d13-pf- d13bridges@uscg.mil. 
SUPPLEMENTARY INFORMATION : On July 
19, 2018, we published a temporary deviation entitled ‘‘Drawbridge Operation Regulation; Willamette River at Portland, OR’’ in the Federal Register (83 FR 34041). That temporary deviation allowed the subject bridge to not open to marine vessels from 6 p.m. on September 1, 2018 to 12:01 a.m. on September 2, 2018. Multnomah County, the bridge owner, requested a modification of the current published deviation to the following times: 6 p.m. on September 8, 2018, to 12:01 a.m. on September 9, 2018. This change is due to scheduling issues with the filming crew for a movie. 
The Hawthorne Bridge provides a 
vertical clearance of 49 feet in the closed-to-navigation position referenced to the vertical clearance above Columbia River Datum 0.0. The subject bridge operates per 33 CFR 117.897(c)(3)(v). Waterway usage on this part of the Willamette River includes vessels ranging from commercial tug and barge to small pleasure craft. The Coast Guard requested objections to this modification from local mariners via email. No objections were submitted to us. Waterway usage on this part of the Willamette River includes vessels ranging from commercial tug and barge to small pleasure craft. 
Vessels able to pass through the 
bridge in the closed-to-navigation position may do so at any time. The bridge will be able to open for emergencies, and there is no immediate alternate route for vessels to pass. The Coast Guard will inform the users of the waterway, through our Local and Broadcast Notices to Mariners, of the change in operating schedule for the bridge so that vessel operators can arrange their transits to minimize any impact caused by the temporary deviation. 
In accordance with 33 CFR 117.35(e), 
the drawbridge must return to its regular operating schedule immediately at the end of the effective period of this temporary deviation. This deviation from the operating regulations is authorized under 33 CFR 117.35. Dated: August 9, 2018. 
Steven M. Fischer, 
Bridge Administrator, Thirteenth Coast Guard 
District. 
[FR Doc. 2018–17800 Filed 8–16–18; 8:45 am] 
BILLING CODE 9110–04–P 
ENVIRONMENTAL PROTECTION 
AGENCY 
40 CFR Parts 9 and 721 
[EPA–HQ–OPPT–2017–0414; FRL–9971–37] 
RIN 2070–AB27 
Significant New Use Rules on Certain 
Chemical Substances 
AGENCY : Environmental Protection 
Agency (EPA). 
ACTION : Direct final rule. 
SUMMARY : EPA is promulgating 
significant new use rules (SNURs) under the Toxic Substances Control Act (TSCA) for 27 chemical substances which were the subject of premanufacture notices (PMNs). The chemical substances are subject to Orders issued by EPA pursuant to section 5(e) of TSCA. This action requires persons who intend to manufacture (defined by statute to include import) or process any of these 27 chemical substances for an activity that is designated as a significant new use by this rule to notify EPA at least 90 days before commencing that activity. The required notification initiates EPA’s evaluation of the intended use within the applicable review period. Persons may not commence manufacture or processing for the significant new use until EPA has conducted a review of the notice, made an appropriate determination on the notice, and has taken such actions as are required with that determination. 
DATES : This rule is effective on October 
16, 2018. For purposes of judicial review, this rule shall be promulgated at 1 p.m. (e.s.t.) on August 31, 2018. 
Written adverse comments on one or 
more of these SNURs must be received on or before September 17, 2018 (see Unit VI. of the 
SUPPLEMENTARY  
INFORMATION ). If EPA receives written 
adverse comments on one or more of these SNURs before September 17, 2018, EPA will withdraw the relevant sections of this direct final rule before its effective date. 
For additional information on related 
reporting requirement dates, see Units I.A., VI., and VII. of the 
SUPPLEMENTARY  
INFORMATION . 
ADDRESSES : Submit your comments, 
identified by docket identification (ID) 
VerDate Sep<11>2014 16:27 Aug 16, 2018 Jkt 244001 PO 00000 Frm 00056 Fmt 4700 Sfmt 4700 E:\FR\FM\17AUR1.SGM 17AUR1daltland on DSKBBV9HB2PROD with RULES40987 Federal Register / Vol. 83, No. 160 / Friday, August 17, 2018 / Rules and Regulations 
number EPA–HQ–OPPT–2017–0414, by 
one of the following methods: 
•Federal eRulemaking Portal: http:// 
www.regulations.gov. Follow the online 
instructions for submitting comments. Do not submit electronically any information you consider to be Confidential Business Information (CBI) or other information whose disclosure is restricted by statute. 
•Mail: Document Control Office 
(7407M), Office of Pollution Prevention and Toxics (OPPT), Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460–0001. 
•Hand Delivery: To make special 
arrangements for hand delivery or delivery of boxed information, please follow the instructions at http://www.epa.gov/dockets/contacts.html. 
Additional instructions on 
commenting or visiting the docket, along with more information about dockets generally, is available at http:// 
www.epa.gov/dockets. 
FOR FURTHER INFORMATION CONTACT : 
For technical information contact: 
Kenneth Moss, Chemical Control Division (7405M), Office of Pollution Prevention and Toxics, Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460–0001; telephone number: (202) 564–9232; email address: moss.kenneth@epa.gov. 
For general information contact: The 
TSCA-Hotline, ABVI-Goodwill, 422 South Clinton Ave., Rochester, NY 14620; telephone number: (202) 554– 1404; email address: TSCA-Hotline@epa.gov. 
SUPPLEMENTARY INFORMATION : 
I. General Information 
A. Does this action apply to me? 
You may be potentially affected by 
this action if you manufacture, process, 
or use the chemical substances contained in this rule. The following list of North American Industrial Classification System (NAICS) codes is not intended to be exhaustive, but rather provides a guide to help readers determine whether this document applies to them. Potentially affected entities may include: 
•Manufacturers or processors of one 
or more subject chemical substances (NAICS codes 325 and 324110), e.g., chemical manufacturing and petroleum refineries. 
This action may also affect certain 
entities through pre-existing import certification and export notification rules under TSCA. Chemical importers are subject to the TSCA section 13 (15 U.S.C. 2612) import certification requirements promulgated at 19 CFR 12.118 through 12.127 and 19 CFR 127.28. Chemical importers must certify that the shipment of the chemical substance complies with all applicable rules and orders under TSCA. Importers of chemicals subject to these SNURs must certify their compliance with the SNUR requirements. The EPA policy in support of import certification appears at 40 CFR part 707, subpart B. In addition, any persons who export or intend to export a chemical substance that is the subject of this rule on or after September 17, 2018 are subject to the export notification provisions of TSCA section 12(b) (15 U.S.C. 2611(b)) (see § 721.20), and must comply with the export notification requirements in 40 CFR part 707, subpart D. 
B. What should I consider as I prepare 
my comments for EPA? 
1. Submitting CBI. Do not submit this 
information to EPA through regulations.gov or email. Clearly mark 
the part or all of the information that you claim to be CBI. For CBI information in a disk or CD–ROM that you mail to EPA, mark the outside of the disk or CD–ROM as CBI and then identify electronically within the disk or CD–ROM the specific information that is claimed as CBI. In addition to one complete version of the comment that includes information claimed as CBI, a copy of the comment that does not contain the information claimed as CBI must be submitted for inclusion in the public docket. Information so marked will not be disclosed except in accordance with procedures set forth in 40 CFR part 2. 
2. Tips for preparing your comments. 
When preparing and submitting your comments, see the commenting tips at http://www.epa.gov/dockets/ comments.html. 
II. Background A. What action is the Agency taking? 
1. Direct Final Rule. EPA is 
promulgating these SNURs using direct 
final procedures. These SNURs will require persons to notify EPA at least 90 days before commencing the manufacture or processing of a chemical substance for any activity designated by these SNURs as a significant new use. Receipt of such notices obligates EPA to assess risks that may be associated with the significant new uses under the conditions of use and, if appropriate, to regulate the proposed uses before they occur. 
2. Proposed Rule. In addition to this 
Direct Final Rule, elsewhere in this issue of the Federal Register, EPA is 
issuing a Notice of Proposed Rulemaking for this rule. If EPA receives no adverse comment, the Agency will 
not take further action on the proposed rule and the direct final rule will become effective as provided in this action. If EPA receives adverse comment on one or more of SNURs in this action by September 17, 2018 (see Unit VI. of the 
SUPPLEMENTARY INFORMATION ), the 
Agency will publish in the Federal Register a timely withdrawal of the 
specific SNURs that the adverse comments pertain to, informing the public that the actions will not take effect. EPA would then address all adverse public comments in a response to comments document in a subsequent final rule, based on the proposed rule. 
B. What is the Agency’s authority for 
taking this action? 
Section 5(a)(2) of TSCA (15 U.S.C. 
2604(a)(2)) authorizes EPA to determine that a use of a chemical substance is a ‘‘significant new use.’’ EPA must make this determination by rule after considering all relevant factors, including the four bulleted TSCA section 5(a)(2) factors listed in Unit III. Once EPA determines that a use of a chemical substance is a significant new use, TSCA section 5(a)(1)(B) requires persons to submit a significant new use notice (SNUN) to EPA at least 90 days before they manufacture or process the chemical substance for that use (15 U.S.C. 2604(a)(1)(B)(i)). TSCA furthermore prohibits such manufacturing or processing from commencing until EPA has conducted a review of the notice, made an appropriate determination on the notice, and taken such actions as are required in association with that determination (15 U.S.C. 2604(a)(1)(B)(ii)). As 
described in Unit V., the general SNUR provisions are found at 40 CFR part 721, subpart A. 
C. Applicability of General Provisions 
General provisions for SNURs appear 
in 40 CFR part 721, subpart A. These 
provisions describe persons subject to the rule, recordkeeping requirements, exemptions to reporting requirements, and applicability of the rule to uses occurring before the effective date of the rule. Provisions relating to user fees appear at 40 CFR part 700. According to § 721.1(c), persons subject to these SNURs must comply with the same SNUN requirements and EPA regulatory procedures as submitters of PMNs under TSCA section 5(a)(1)(A). In particular, these requirements include the information submission requirements of TSCA section 5(b) and 5(d)(1), the exemptions authorized by TSCA section 5(h)(1), (h)(2), (h)(3), and (h)(5), and the regulations at 40 CFR part 720. Once 
VerDate Sep<11>2014 16:27 Aug 16, 2018 Jkt 244001 PO 00000 Frm 00057 Fmt 4700 Sfmt 4700 E:\FR\FM\17AUR1.SGM 17AUR1daltland on DSKBBV9HB2PROD with RULES40988 Federal Register / Vol. 83, No. 160 / Friday, August 17, 2018 / Rules and Regulations 
EPA receives a SNUN, EPA must either 
determine that the significant new use is not likely to present an unreasonable risk of injury or take such regulatory action as is associated with an alternative determination before the manufacture or processing for the significant new use can commence. If EPA determines that the significant new use is not likely to present an unreasonable risk, EPA is required under TSCA section 5(g) to make public, and submit for publication in the Federal Register, a statement of EPA’s findings. 
III. Significant New Use Determination 
Section 5(a)(2) of TSCA states that 
EPA’s determination that a use of a 
chemical substance is a significant new use must be made after consideration of all relevant factors, including: 
•The projected volume of 
manufacturing and processing of a chemical substance. 
•The extent to which a use changes 
the type or form of exposure of human beings or the environment to a chemical substance. 
•The extent to which a use increases 
the magnitude and duration of exposure of human beings or the environment to a chemical substance. 
•The reasonably anticipated manner 
and methods of manufacturing, processing, distribution in commerce, and disposal of a chemical substance. 
In addition to these factors 
enumerated in TSCA section 5(a)(2), the statute authorizes EPA to consider any other relevant factors. 
To determine what would constitute a 
significant new use for the chemical substances that are the subject of these SNURs, EPA considered relevant information about the toxicity of the chemical substances, likely human exposures and environmental releases associated with possible uses, and the four bulleted TSCA section 5(a)(2) factors listed in this unit. 
IV. Substances Subject to This Rule 
EPA is establishing significant new 
use and recordkeeping requirements for 
27 chemical substances in 40 CFR part 721, subpart E. In this unit, EPA provides the following information for each chemical substance: 
•PMN number. 
•Chemical name (generic name, if 
the specific name is claimed as CBI). 
•Chemical Abstracts Service (CAS) 
Registry number (if assigned for non- confidential chemical identities). 
•Basis for the TSCA section 5(e) 
Order. 
•Information identified by EPA that 
would help characterize the potential health and/or environmental effects of 
the chemical substance in support of a request by the PMN submitter to modify the Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use designated by the SNUR. 
This information may include testing 
required in a TSCA section 5(e) Order to be conducted by the PMN submitter, as well as testing not required to be conducted but which would also help characterize the potential health and/or environmental effects of the PMN substance. Any recommendation for information identified by EPA was made based on EPA’s consideration of available screening-level data, if any, as well as other available information on appropriate testing for the chemical substance. Further, any such testing identified by EPA that includes testing on vertebrates was made after consideration of available toxicity information, computational toxicology and bioinformatics, and high- throughput screening methods and their prediction models. EPA also recognizes that whether testing/further information is needed will depend on the specific exposure and use scenario in the SNUN. EPA encourages all SNUN submitters to contact EPA to discuss any potential future testing. See Unit VIII. for more information. 
•CFR citation assigned in the 
regulatory text section of this rule. 
The regulatory text section of each 
rule specifies the activities designated as significant new uses. Certain new uses, including exceedance of production volume limits (i.e., limits on 
manufacture volume) and other uses designated in this rule, may be claimed 
as CBI. Unit IX. discusses a procedure companies may use to ascertain whether a proposed use constitutes a significant new use. 
These rules include 27 PMN 
substances that are subject to Orders issued under TSCA section 5(e)(1)(A)(ii)(I) where EPA determined that it has insufficient information to conduct a reasoned evaluation and the activities associated with the PMN substances may present unreasonable risk to human health or the environment. Those Orders require protective measures to limit exposures or otherwise mitigate the potential unreasonable risk. The SNURs identify as significant new uses any manufacturing, processing, use, distribution in commerce, or disposal that does not conform to the restrictions imposed by the underlying Orders, consistent with TSCA section 5(f)(4). 
Where EPA determined that the PMN 
substance may present an unreasonable risk of injury to human health via 
inhalation exposure, the underlying TSCA section 5(e) Order usually requires, among other things, that potentially exposed employees wear specified respirators unless actual measurements of the workplace air show that air-borne concentrations of the PMN substance are below a New Chemical Exposure Limit (NCEL) that is established by EPA to provide adequate protection to human health. In addition to the actual NCEL concentration, the comprehensive NCELs provisions in TSCA section 5(e) Orders, which are modeled after Occupational Safety and Health Administration (OSHA) Permissible Exposure Limits (PELs) provisions, include requirements addressing performance criteria for sampling and analytical methods, periodic monitoring, respiratory protection, and recordkeeping. However, no comparable NCEL provisions currently exist in 40 CFR part 721, subpart B, for SNURs. Therefore, for these cases, the individual SNURs in 40 CFR part 721, subpart E, will state that persons subject to the SNUR who wish to pursue NCELs as an alternative to the § 721.63 respirator requirements may request to do so under § 721.30. EPA expects that persons whose § 721.30 requests to use the NCELs approach for SNURs that are approved by EPA will be required to comply with NCELs provisions that are 
comparable to those contained in the corresponding TSCA section 5(e) Order for the same chemical substance. 
PMN Numbers: P–12–277, P–12–278, P– 
12–280, P–12–281, P–12–282, P–12–283, and P–12–284 
Chemical names: Alkanes, C
20–28, 
chloro (P–12–277), Slack waxes (petroleum), chloro (P–12–278), Hexacosane, chloro derivs. and octacosane, chloro derivs. (P–12–280), Alkanes, C
20–24, chloro (P–12–281), 
Alkanes, C 14–16, chloro (P–12–282), 
Tetradecane, chloro derivs. (P–12–283), and Octadecane, chloro derivs. (P–12– 284). 
CAS numbers: 2097144–43–7 (P–12– 
277), 2097144–44–8 (P–12–278), 2097144–46–0 and 2097144–47–1 (P– 12–280), 2097144–45–9 (P–12–281), 1372804–76–6 (P–12–282), 198840–65– 2 (P–12–283), 2097144–48–2 (P–12– 284). 
Effective date of TSCA section 5(e) 
Order: June 5, 2017. 
Basis for TSCA section 5(e) Order: 
The PMNs state that the PMN substances will be used as flame retardants and plasticizers in polyvinyl chloride (PVC), polymers, and rubber; flame retardants, plasticizers, and 
VerDate Sep<11>2014 16:27 Aug 16, 2018 Jkt 244001 PO 00000 Frm 00058 Fmt 4700 Sfmt 4700 E:\FR\FM\17AUR1.SGM 17AUR1daltland on DSKBBV9HB2PROD with RULES40989 Federal Register / Vol. 83, No. 160 / Friday, August 17, 2018 / Rules and Regulations 
lubricants in adhesives, caulk, sealants, 
and coatings; additives in lubricants including metalworking fluids; and flame retardants and waterproofers in textiles. Based on the physical/chemical properties of the PMN substances (as described in the New Chemical Program’s PBT category at 64 FR 60194; November 4, 1999; FRL–6097–7) and test data on structurally similar medium-chain chlorinated paraffins (MCCP), the PMN substances are a potentially persistent, bioaccumulative, and toxic (PBT) chemicals. EPA estimates that the PMN substances will persist in the environment more than 2 months and estimates a bioaccumulation factor of greater than or equal to 1,000. Based on data on MCCP, EPA has identified concerns for systemic toxicity as well as aquatic and terrestrial toxicity. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that the substances may present an unreasonable risk of injury to health or the environment. To protect against these risks, the Order requires: 
1. Submission of certain toxicity 
testing on the representative congener groups prior to exceeding a certain time period specified in the Order. 
2. Use of the PMN substances only for 
the uses specified in the Order: Flame retardants and plasticizers in PVC, polymers, and rubber; flame retardants, plasticizers, and lubricants in adhesives, caulk, sealants, and coatings; additives in lubricants including metalworking fluids; and flame retardants and waterproofers in textiles. 
The SNUR would designate as a 
‘‘significant new use’’ the absence of these protective measures. 
Potentially useful information: EPA 
has determined that certain information about the fate, and terrestrial and aquatic toxicity of the PMN substances may be potentially useful to characterize the effects of the PMN substances in support of a request by the PMN submitter to modify the Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that will be designated by this SNUR. The submitter has agreed not to exceed a certain time limit without performing chronic aquatic and terrestrial toxicity and biodegradation testing. 
CFR citations: 40 CFR 721.11068 (P– 
12–277), 40 CFR 721.11069 (P–12–278), 40 CFR 721.11070 (P–12–280), 40 CFR 721.11071 (P–12–281), 40 CFR 721.11072 (P–12–282 and P–14–684), 40 CFR 721.11073 (P–12–283 and P–14– 683), and 40 CFR 721.11074 (P–12–284). PMN Numbers: P–12–433, P–12–453, and P–12–505 
Chemical names: Alkanes, C
18–20, 
chloro (P–12–433), Alkanes, C 14–17, 
chloro (P–12–453) and Alkanes, C 22–30, 
chloro (P–12–505). 
CAS numbers: 106262–85–3 (P–12– 
433), 85535–85–9 (P–12–453) and 288260–42–4 (P–12–505). 
Effective date of TSCA section 5(e) 
Order: June 5, 2017. 
Basis for TSCA section 5(e) Order: 
The PMN states that the PMN substances will be used as flame retardants and plasticizers in PVC, polymers, and rubber; flame retardants, plasticizers, and lubricants in adhesives, caulk, sealants, and coatings; additives in lubricants including metalworking fluids; and flame retardants and waterproofers in textiles. Based on the physical/chemical properties of the PMN substances (as described in the New Chemical Program’s PBT category at 64 FR 60194; November 4, 1999; FRL–6097–7) and test data on structurally similar medium-chain chlorinated paraffins (MCCP), the PMN substances are potentially persistent, bioaccumulative, and toxic (PBT) chemicals. EPA estimates that the PMN substances will persist in the environment more than 2 months and estimates a bioaccumulation factor of greater than or equal to 1,000. Based on test data on MCCP EPA has identified concerns for systemic toxicity as well as aquatic and terrestrial toxicity. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that the substances may present an unreasonable risk of injury to health or the environment. To protect against these risks, the Order requires: 
1. Submission of certain toxicity 
testing on the representative congener groups prior to exceeding a certain time period specified in the Order. 
2. Use of the PMN substances only for 
the uses specified in the Order: Flame retardants and plasticizers in PVC, polymers, and rubber; flame retardants, plasticizers, and lubricants in adhesives, caulk, sealants, and coatings; additives in lubricants including metalworking fluids; and flame retardants and waterproofers in textiles. 
The SNUR would designate as a 
‘‘significant new use’’ the absence of these protective measures. 
Potentially useful information: EPA 
has determined that certain information about the fate, and terrestrial and aquatic toxicity of the PMN substances may be potentially useful to characterize the effects of the PMN substances in support of a request by the PMN submitter to modify the Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that will be designated by this SNUR. The submitter has agreed not to exceed a certain time limit without performing chronic aquatic and terrestrial toxicity and biodegradation testing. 
CFR citations: 40 CFR 721.11075 (P– 
12–433), 40 CFR 721.11076 (P–12–453), 40 CFR 721.11077 (P–12–505). 
PMN Numbers: P–14–683 and P–14–684 
Chemical names: Tetradecane, chloro 
derivs. (P–14–683) and Alkanes, C
14–16, 
chloro (P–14–684). 
CAS numbers: 198840–65–2 (P–14– 
683) and 1372804–76–6 (P–14–684). 
Effective date of TSCA section 5(e) 
Order: May 17, 2017. 
Basis for TSCA section 5(e) Order: 
The PMNs state that the substances will 
be used as flame retardants and plasticizers in PVC, polymers, and rubber; flame retardants, plasticizers, and lubricants in adhesives, caulk, sealants, and coatings; additives in lubricants including metalworking fluids; and flame retardants and waterproofers in textiles. Based on the physical/chemical properties of the PMN substances (as described in the New Chemical Program’s PBT category at 64 FR 60194; November 4, 1999; FRL–6097–7) and test data on structurally similar medium-chain chlorinated paraffins (MCCP), the PMN substances are potentially persistent, bioaccumulative, and toxic (PBT) chemicals. EPA estimates that the PMN substances will persist in the environment more than 2 months and estimates a bioaccumulation factor of greater than or equal to 1,000. Further, EPA has identified concerns for systemic toxicity, as well as aquatic and terrestrial toxicity. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that the substances may present an unreasonable risk of injury to health or the environment. To protect against these risks, the Order requires: 
1. Submission of certain toxicity 
testing on the representative congener groups prior to exceeding a certain time period specified in the Order. 
2. Use of the PMN substances only for 
the uses specified in the Order: Flame retardants and plasticizers in PVC, polymers, and rubber; flame retardants, plasticizers, and lubricants in adhesives, caulk, sealants, and coatings; additives in lubricants including metalworking fluids; and flame retardants and waterproofers in textiles. 
VerDate Sep<11>2014 16:27 Aug 16, 2018 Jkt 244001 PO 00000 Frm 00059 Fmt 4700 Sfmt 4700 E:\FR\FM\17AUR1.SGM 17AUR1daltland on DSKBBV9HB2PROD with RULES40990 Federal Register / Vol. 83, No. 160 / Friday, August 17, 2018 / Rules and Regulations 
The SNUR would designate as a 
‘‘significant new use’’ the absence of 
these protective measures. 
Potentially useful information: EPA 
has determined that certain information about the fate, and terrestrial and aquatic toxicity of the PMN substances may be potentially useful to characterize the effects of the PMN substances in support of a request by the PMN submitter to modify the Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that will be designated by this SNUR. The submitter has agreed not to exceed a certain time limit without performing chronic aquatic and terrestrial toxicity and biodegradation testing. 
CFR citations: 40 CFR 721.11072 (P– 
12–282 and P–14–684), 40 CFR 721.11073 (P–12–283 and P–14–683). 
PMN Number: P–16–150 
Chemical name: Chloroflurocarbon 
(generic). 
CAS number: Not available. 
Effective date of TSCA section 5(e) 
Order: May 31, 2017. 
Basis for TSCA section 5(e) Order: 
The PMN states that the generic (non- 
confidential) use of the substance will be as an intermediate. Based on test data on the PMN substance, EPA identified concerns for acute human toxicity. Based on analogue data EPA identified concerns for toxicity to aquatic and terrestrial organisms. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I), 5(a)(3)(B)(ii)(II) and 5(e)(1)(A)(ii)(I), based on a finding that the substance may present an unreasonable risk of injury to health and the environment and that the substance will be produced in substantial quantities and may be reasonably anticipated to enter the environment in substantial quantities. To protect against these risks, the Order requires: 
1. Submission of certain toxicity 
testing on the substance prior to exceeding the production limits specified in the Order. 
2. Use of personal protective 
equipment to prevent dermal exposure (where there is a potential for dermal exposure). 
3. Use of a National Institute of 
Occupational Safety and Health (NIOSH)-certified respirator with an assigned protection factor (APF) of at least 1000 (where there is a potential for inhalation exposure) in conjunction with a minimum set of engineering controls described in the PMN, or compliance with a new chemical exposure limit (NCEL) of 170 parts per billion (ppb) as an 8-hour time-weighted average to prevent inhalation exposure. 4. Use of engineering controls to limit 
worker exposure and air release of the PMN substance to the environment. 
5. Establishment and use of a hazard 
communication program, including human health precautionary statements on each label and in the Safety Data Sheet (SDS). 
6. Manufacture, processing, and use 
in an enclosed process. 
7. Use only as a chemical 
intermediate. 
8. No release of the substance 
resulting in surface water concentrations that exceed 240 ppb. 
The SNUR would designate as a 
‘‘significant new use’’ the absence of these protective measures. 
Potentially useful information: EPA 
has determined that certain information about the human health and aquatic toxicity of the PMN substance may be potentially useful to characterize the effects of the PMN substance in support of a request by the PMN submitter to modify the Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that will be designated by this SNUR. The submitter has agreed not to exceed the confidential production limit without performing specific target organ toxicity testing, reproductive and developmental toxicity testing, and acute and chronic aquatic toxicity testing. 
CFR citation: 40 CFR 721.11078. 
PMN Number: P–16–379 
Chemical name: Silane, 1,1′-(1,2- 
ethanediyl)bis[1,1-dichloro-1-methyl]-, hydrolysis products with chloroethenyldimethylsilane. 
CAS number: 1485477–78–8. 
Effective date of TSCA section 5(e) 
Order: June 8, 2017. 
Basis for TSCA section 5(e) Order: 
The PMN states that the generic (non- 
confidential) use of the substance is as a chemical intermediate for polymer synthesis. Based on SAR analysis of test data on analogous substances, EPA has identified concerns for liver toxicity and mutagenicity. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that the substances may present an unreasonable risk of injury to health and the environment. To protect against these risks, the Order requires: 
1. Submission of certain toxicity 
testing on the substance prior to exceeding the confidential production volume limit specified in the Order. 
2. Use of personal protective 
equipment including impervious gloves and clothing which covers any other exposed areas of the arms, legs and torso (where there is a potential for dermal exposure). 3. Establishment and use of a hazard 
communication program, including human health precautionary statements on each label and in the SDS. 
4. No domestic manufacture of the 
substance. 
5. Use of the substance only for the 
confidential uses specified in the Order. 
6. No use involving application 
methods that generate a dust, mist, vapor, or aerosol. 
7. Disposal of the substance only by 
water or landfill. 
The SNUR would designate as a 
‘‘significant new use’’ the absence of these protective measures. 
Potentially useful information: EPA 
has determined that certain information about the human health toxicity of the PMN substance may be potentially useful to characterize the effects of the PMN substance in support of a request by the PMN submitter to modify the Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that will be designated by this SNUR. The submitter has agreed not to exceed the confidential production limit without performing specific target organ toxicity and mutagenicity testing. In addition, EPA has determined that the results of other specific target organ toxicity testing of the PMN substance may be potentially useful in characterizing the health effects of the PMN substance. Although the Order does not require this additional testing, the Order’s restrictions on manufacture, processing, distribution in commerce, use, and disposal will remain in effect until the Order is modified or revoked by EPA based on submission of this or other information that EPA determines is relevant and needed to evaluate a modification request. 
CFR citation: 40 CFR 721.11079. 
PMN Number: P–16–410 
Chemical name: Silicophosphonate— 
sodium silicate (generic). 
CAS number: Not available. 
Effective date of TSCA section 5(e) 
Order: May 4, 2017. 
Basis for TSCA section 5(e) Order: 
The PMN states that the generic (non- 
confidential) use of the substance will be as an automotive engine fluid additive. Based on test data on the PMN substance, EPA has identified concerns for skin and eye irritation, corrosion, and systemic toxicity. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that the substance may present an unreasonable risk of injury to human health. To protect against these risks, the Order requires: 
VerDate Sep<11>2014 16:27 Aug 16, 2018 Jkt 244001 PO 00000 Frm 00060 Fmt 4700 Sfmt 4700 E:\FR\FM\17AUR1.SGM 17AUR1daltland on DSKBBV9HB2PROD with RULES40991 Federal Register / Vol. 83, No. 160 / Friday, August 17, 2018 / Rules and Regulations 
1. No domestic manufacture of the 
substance. 
2. Use of the substance in 
formulations containing no greater than 
0.2% of the chemical substance and for the confidential uses specified in the Order. 
The SNUR would designate as a 
‘‘significant new use’’ the absence of these protective measures. 
Potentially useful information: EPA 
has determined that certain information about the human health toxicity of the PMN substance may be potentially useful to characterize the effects of the substance in support of a request by the PMN submitter to modify the Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that will be designated by this SNUR. EPA has determined that the results of irritation testing may be potentially useful in characterizing the health effects of the PMN substance. Although the Order does not require these tests, the Order’s restrictions on manufacture, processing, distribution in commerce, use, and disposal will remain in effect until the Order is modified or revoked by EPA based on submission of this or other information that EPA determines is relevant and needed to evaluate a modification request. 
CFR citation: 40 CFR 721.11080. 
PMN Number: P–16–438 
Chemical name: 3-Butenenitrile, 2- 
(acetyloxy)-. 
CAS number: 15667–63–7. 
Effective date of TSCA section 5(e) 
Order: June 23, 2017. 
Basis for TSCA section 5(e) Order: 
The PMN states the substance will be 
used as a chemical intermediate for a pesticide inert. Based on test data on the PMN substance, EPA identified concerns for acute toxicity, irritation to all tissues, developmental toxicity, and neurotoxicity. EPA identified concerns for aquatic organism toxicity based on submitted data. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that the substance may present an unreasonable risk of injury to health and the environment. Further, based on SAR analysis of test data on analogous vinyl/ allyl esters vinyl/allyl esters nitriles and test data on the PMN substance, EPA predicts toxicity to aquatic organisms may occur at concentrations that exceed 8 ppb in surface waters. To protect against these risks, the Order requires: 
1. Submission of monitoring data on 
the substance. 
2. Use of personal protective 
equipment including impervious gloves and protective clothing (where there is a potential for dermal exposures) and a NIOSH-certified powered air purifying particulate respirator with an Assigned Protection Factor (APF) of at least 1000 (where there is a potential for inhalation exposures). 
3. Establishment and use of a hazard 
communication program, including human health precautionary statements on each label and in the SDS. 
4. Manufacture, process, and use of 
the substance in a closed system as specified in the PMN. 
5. Use of the substance only as a 
chemical intermediate. 
6. No release of the substance into the 
surface waters of the United States. 
The SNUR would designate as a 
‘‘significant new use’’ the absence of these protective measures. 
Potentially useful information: EPA 
has determined that certain information about the aquatic toxicity of the PMN substance may be potentially useful to characterize the effects of the PMN substance in support of a request by the PMN submitter to modify the Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that will be designated by this SNUR. EPA has determined that the results of chronic aquatic toxicity testing of the PMN substance may be potentially useful in characterizing the environmental effects of the PMN substance. Although the Order does not require these tests, the Order’s restrictions on manufacture, processing, distribution in commerce, and use will remain in effect until the Order is modified or revoked by EPA based on submission of this or other information that EPA determines is relevant and needed to evaluate a modification request. 
CFR citation: 40 CFR 721.11081. 
PMN Number: P–16–543 
Chemical name: Halogenophosphoric 
acid metal salt (generic). 
CAS number: Not available. 
Effective date of TSCA section 5(e) 
Order: May 24, 2017. 
Basis for TSCA section 5(e) Order: 
The PMN states that the generic (non- 
confidential) use will be as a battery ingredient. Based on test data on the PMN substance and an analogue, EPA has identified concerns for irritation, corrosion, acute toxicity, immunotoxicity, developmental toxicity, neurotoxicity, and cancer. Further, based on test data on the PMN substance, EPA identified concerns for aquatic organism toxicity at surface water concentrations that exceed 3 ppb. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that the substance may present an unreasonable risk of injury to health and the environment. To protect against these risks, the Order requires: 
1. Submission of monitoring data as 
specified in the Order. 
2. Use of personal protective 
equipment as specified in the Order (where there is a potential for dermal exposure). 
3. Use of a NIOSH-certified respirator 
with an APF of at least 1000 (where there is a potential for inhalation exposure). 
4. Establishment and use of a hazard 
communication program, including human health precautionary statements on each label and in the SDS. 
5. No domestic manufacture of the 
substance. 
6. Use of the substance only in an 
enclosed process. 
7. Use of the substance only for the 
confidential uses specified in the Order. 
8. Manufacture, process, or use of the 
substance without the engineering controls required by the Order to control dermal and inhalation exposure. 
9. Disposal of the substance by 
hazardous waste incineration except when in wastewater. 
10. No release of the substance 
resulting in surface water concentrations that exceed 3 ppb. 
The SNUR would designate as a 
‘‘significant new use’’ the absence of these protective measures. 
Potentially useful information: EPA 
has determined that certain information about the human health toxicity, human exposure, aquatic toxicity, and fate of the PMN substance may be potentially useful to characterize the effects of the PMN substance in support of a request by the PMN submitter to modify the Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that will be designated by this SNUR. The submitter has agreed to conduct an exposure monitoring program for employees who are reasonably likely to be exposed to the PMN substance and a hydrolysis product of the PMN substance. In addition, EPA has determined that the results of specific target organ toxicity, acute aquatic toxicity, and biodegradation testing of the PMN substance may be potentially useful in characterizing the health and environmental effects of the PMN substance. Although the Order does not require this additional testing, the Order’s restrictions on manufacture, processing, distribution in commerce, use, and disposal will remain in effect until the Order is modified or revoked by EPA based on submission of this or other information that EPA determines 
VerDate Sep<11>2014 16:27 Aug 16, 2018 Jkt 244001 PO 00000 Frm 00061 Fmt 4700 Sfmt 4700 E:\FR\FM\17AUR1.SGM 17AUR1daltland on DSKBBV9HB2PROD with RULES40992 Federal Register / Vol. 83, No. 160 / Friday, August 17, 2018 / Rules and Regulations 
is relevant and needed to evaluate a 
modification request. 
CFR citation: 40 CFR 721.11082. 
PMN Number: P–16–596 
Chemical names: Alkenoic acid, 
reaction products with polyethylene glycol ether with hydroxyalkyl substituted alkane (generic). 
CAS numbers: Not available. 
Effective date of TSCA section 5(e) 
Order: June 5, 2017. 
Basis for TSCA section 5(e) Order: 
The PMN states that the substance will 
be used as a site-limited intermediate used for production of ultraviolet (UV) curable coating resin. Based on SAR analysis on structurally similar substances, EPA has identified concerns for irritation, sensitization, developmental toxicity, liver and kidney effects, and oncogenicity. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that the substances may present an unreasonable risk of injury to health and the environment. EPA’s estimates indicate that variations of the parameters (including batch size, number of processing sites, days per year of operation) of the uses identified below would not result in inhalation exposure. To protect against these risks, the Order requires: 
1. Submission of test data on the 
substance prior to exceeding the confidential production volume limit specified in the Order. 
2. Use of personal protective 
equipment including impervious gloves (where there is a potential for dermal exposure). 
3. Establishment and use of a hazard 
communication program, including human health precautionary statements on each label and in the SDS. 
4. No domestic manufacture of the 
substance. 
5. Use of the substance only as a site- 
limited intermediate for the production of UV curable coating resin. 
6. No release of the substance to 
surface waters of the United States. 
The SNUR would designate as a 
‘‘significant new use’’ the absence of these protective measures. 
Potentially useful information: EPA 
has determined that certain information about the human health toxicity of the PMN substance may be potentially useful to characterize the effects of the PMN substances in support of a request by the PMN submitter to modify the Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that will be designated by this SNUR. EPA has determined that the results of a reproductive/developmental toxicity testing may be potentially useful in characterizing the health effects of the PMN substance. The submitter has agreed not to manufacture beyond a certain production volume limit without performing reproductive/developmental toxicity testing. 
CFR citation: 40 CFR 721.11083. 
PMN Number: P–17–10 
Chemical name: Alkyl substituted 
alkenoic acid, alkyl ester, polymer with alkyl substituted alkenoate and alkenoic acid, hydroxy substituted[(oxoalkyl)oxy]alkyl ester, reaction products with alkanoic acid, dipentaerythritil and isocyanate substituted carbomonocycle, compds. with alkylamine (generic). 
CAS number: Not available. 
Effective date of TSCA section 5(e) 
Order: June 31, 2017. 
Basis for TSCA section 5(e) Order: 
The PMN states that the substance will 
be used as a UV curable coating resin. Based on test data on structurally similar substances, EPA has identified concerns for irritation, sensitization, developmental effects, internal organ effects (liver and kidney), and cancer. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that the substance may present an unreasonable risk of injury to health and the environment. To protect against these risks, the Order requires: 
1. Use of personal protective 
equipment including impervious gloves to prevent dermal exposure (where there is a potential for dermal exposure). 
2. Establishment and use of a hazard 
communication program, including human health precautionary statements on each label and in the SDS. 
3. No domestic manufacture of the 
substance. 
4. No manufacture, process, or use of 
the substance that results in generation of a vapor, mist, or aerosol. 
5. No manufacture of the substance 
where there is more than 0.1% residual isocyanate by weight. 
6. Use of the substance only as a UV 
curable coating resin. 
7. Only import the substance in totes. 
8. Manufacture of the substance to 
have an average molecular weight of 
greater than 2,000 daltons. 
The SNUR would designate as a 
‘‘significant new use’’ the absence of these protective measures. 
Potentially useful information: EPA 
has determined that certain information about the human health toxicity of the PMN substance may be potentially useful to characterize the effects of the PMN substances in support of a request by the PMN submitter to modify the Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that will be designated by this SNUR. EPA has determined that the results of reproductive/developmental toxicity testing may be potentially useful in characterizing the health effects of the PMN substance. Although the Order does not require these tests, the Order’s restrictions on manufacture, processing, distribution in commerce, and use will remain in effect until the Order is modified or revoked by EPA based on submission of this or other information that EPA determines is relevant and needed to evaluate a modification request. 
CFR citation: 40 CFR 721.11084. 
PMN Number: P–17–15 
Chemical name: Heteromonocycle 
ester with alkanediol (generic). 
CAS numbers: Not available. 
Effective date of TSCA section 5(e) 
Order: June 13, 2017. 
Basis for TSCA section 5(e) Order: 
The PMN states that the generic (non- 
confidential) use of the PMN substance is a precursor for a photochromatic substance. Based on SAR analysis of test data on analogous esters, EPA has identified concerns for irritation to skin, eye, and mucous membrane, and systemic toxicity. Further, based on SAR analysis of test data on analogous nonionic esters, EPA predicts toxicity to aquatic organisms may occur at concentrations that exceed 3 ppb of the PMN substance in surface waters. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that the substances may present an unreasonable risk of injury to health and the environment. EPA’s estimates indicate that variations of the parameters (including batch size, number of processing sites, days per year of operation of the uses identified below) would not result in inhalation exposure. To protect against these risks, the Order requires: 
1. Submission of certain toxicity 
testing on the substance prior to exceeding the confidential production volume limit specified in the Order. 
2. Use of personal protective 
equipment including impervious gloves to prevent dermal exposure (where there is a potential for dermal exposure). 
3. Establishment and use of a hazard 
communication program, including human health precautionary statements on each label and in the SDS. 
4. No domestic manufacture of the 
substance. 
5. No use of the substance other than 
other than for the confidential uses identified in the Order. 
VerDate Sep<11>2014 16:27 Aug 16, 2018 Jkt 244001 PO 00000 Frm 00062 Fmt 4700 Sfmt 4700 E:\FR\FM\17AUR1.SGM 17AUR1daltland on DSKBBV9HB2PROD with RULES40993 Federal Register / Vol. 83, No. 160 / Friday, August 17, 2018 / Rules and Regulations 
6. No release of the substance 
resulting in surface water 
concentrations that exceed 3 ppb. 
The SNUR would designate as a 
‘‘significant new use’’ the absence of these protective measures. 
Potentially useful information: EPA 
has determined that certain information about the human health and aquatic toxicity of the PMN substance may be potentially useful to characterize the effects of the PMN substance in support of a request by the PMN submitter to modify the Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that will be designated by this SNUR. The submitter has agreed not to exceed the confidential production limit without performing reproductive/developmental toxicity and acute aquatic toxicity testing. 
CFR citation: 40 CFR 721.11085. 
PMN Number: P–17–29 
Chemical name: Substituted 
carbomonocycle, polymer with (aminoalkyl)-alkanediamine, (haloalkyl)oxirane, dialkyl- alkanediamine and alkyl-alkanamine, reaction products with dialkanolamine and [[(alkyl)oxy]alkyl]oxirane (generic). 
CAS number: Not available. 
Effective date of TSCA section 5(e) 
Order: May 10, 2017. 
Basis for TSCA section 5(e) Order: 
The PMN states that the generic (non- 
confidential) use of the substance is an intermediate prepolymer. Based on the physical/chemical properties of the substance and SAR analysis of test data on analogous aliphatic amines, EPA has identified concerns for irritation, lung effects, and aquatic toxicity. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that the substance may present an unreasonable risk of injury to health and the environment. To protect against these risks, the Order requires: 
1. Submission of certain toxicity 
testing on the substance prior to exceeding the confidential production volume limit specified in the Order. 
2. Use of personal protective 
equipment including impervious gloves to prevent dermal exposure (where there is a potential for dermal exposure). 
3. Establishment and use of a hazard 
communication program, including human health precautionary statements on each label and in the SDS. 
4. No use other than for the 
confidential uses identified in the Order. 
5. No use involving an application 
method that generates a vapor, mist, or aerosol. 6. No domestic manufacture of the 
substance. 
The SNUR would designate as a 
‘‘significant new use’’ the absence of 
these protective measures. 
Potentially useful information: EPA 
has determined that certain information about the human health and aquatic toxicity of the PMN substance may be potentially useful to characterize the effects of the PMN substance in support of a request by the PMN submitter to modify the Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that will 
be designated by this SNUR. The submitter has agreed not to exceed the confidential production limit without performing irritation and acute aquatic toxicity testing. In addition, EPA has determined that the results of a pulmonary effects testing of the PMN substance may be potentially useful in characterizing the health effects of the PMN substance. Although the Order does not require this additional testing, the Order’s restrictions on manufacture, processing, distribution in commerce, use, and disposal will remain in effect until the Order is modified or revoked by EPA based on submission of this or other information that EPA determines is relevant and needed to evaluate a modification request. 
CFR citation: 40 CFR 721.11086. 
PMN Numbers: P–17–154, P–17–155, and P–17–156 
Chemical names: Carboxylic acid 
amine (1:1) (generic) (P–17–154), Mix fatty acids compd. with amine (1:1) (generic) (P–17–155), and Mix fatty acids compd. with amine (1:1) (generic) (P–17–156). 
CAS number: Not available. 
Effective date of TSCA section 5(e) 
Order: June 15, 2017. 
Basis for TSCA section 5(e) Order: 
The PMN states that the generic (non- 
confidential) use of the substances is as a coating. Based on physical/chemical properties of the substances and SAR analysis of test data on amines, EPA identified concerns for irritation, corrosion, developmental toxicity, reproductive toxicity, neurotoxicity, and thyroid toxicity. Further, based on test data on analogous anionic surfactants and aliphatic amines, EPA identified concern for toxicity to aquatic organisms at surface water concentrations that exceed 240 ppb. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that the substances may present an unreasonable risk of injury to health and the environment. EPA’s estimates indicate that variations of the parameters (including batch size, number of processing sites, days per year of operation) of the uses for the chemical substance would not result in increased inhalation exposure. To protect against these risks, the Order requires: 
1. Submission of certain toxicity 
testing on the substances prior to exceeding the confidential production volume limit specified in the Order. 
2. Use of personal protective 
equipment to prevent dermal exposure (where there is a potential for dermal exposure). 
3. Establishment and use of a hazard 
communication program, including human health and environmental precautionary statements on each label and in the SDS. 
The SNUR would designate as a 
‘‘significant new use’’ the absence of these protective measures. 
Potentially useful information: EPA 
has determined that certain information about the human health toxicity of the PMN substances may be potentially useful to characterize the effects of the PMN substances in support of a request by the PMN submitter to modify the Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that will be designated by this SNUR. The submitter has agreed to not exceed a confidential production volume without performing reproductive/developmental toxicity testing. 
CFR citation: 40 CFR 721.11087 (P– 
17–154), 40 CFR 721.11088 (P–17–155), 40 CFR 721.11089 (P–17–156). 
PMN Number: P–17–218 
Chemical name: 
Bicyclo[2.2.1]heptane-1- 
methanesulfonic acid, 7,7-dimethyl-2- oxo-, compd. with N,N- diethylethanamine (1:1). 
CAS number: 67019–84–5. 
Effective date of TSCA section 5(e) 
Order: May 19, 2017. 
Basis for TSCA section 5(e) Order: 
The PMN states that the generic (non- 
confidential) use of the substance is a processing aid for membrane production. Based on SAR analysis of test data on structurally similar respirable particles, EPA identified concerns for corrosivity, irritation, sensitization, developmental toxicity, specific target organ toxicity, and neurotoxicity. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that the substance may present an unreasonable risk of injury to health and the environment. To protect against these risks, the Order requires: 
1. Submission of certain toxicity 
testing on the substance prior to 
VerDate Sep<11>2014 16:27 Aug 16, 2018 Jkt 244001 PO 00000 Frm 00063 Fmt 4700 Sfmt 4700 E:\FR\FM\17AUR1.SGM 17AUR1daltland on DSKBBV9HB2PROD with RULES40994 Federal Register / Vol. 83, No. 160 / Friday, August 17, 2018 / Rules and Regulations 
exceeding the confidential production 
volume limit specified in the Order. 
2. Use of personal protective 
equipment including impervious gloves to prevent dermal exposure (where there is a potential for dermal exposure). 
3. Establishment and use of a hazard 
communication program, including human health precautionary statements on each label and in the SDS. 
4. No manufacture, processing, or use 
involving an application method that generates a vapor, mist, aerosol, or dust. 
The SNUR would designate as a 
‘‘significant new use’’ the absence of these protective measures. 
Potentially useful information: EPA 
has determined that certain information about the human health toxicity of the PMN substance may be potentially useful to characterize the effects of the PMN substance in support of a request by the PMN submitter to modify the Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that will be designated by this SNUR. The submitter has agreed not to exceed the confidential production limit without performing a skin sensitization study. In addition, EPA has determined that the results of reproductive/developmental toxicity testing of the PMN substance may be potentially useful in characterizing the health effects of the PMN substance. Although the Order does not require this additional testing, the Order’s restrictions on manufacture, processing, distribution in commerce, and use will remain in effect until the Order is modified or revoked by EPA based on submission of this or other information that EPA determines is relevant and needed to evaluate a modification request. 
CFR citation: 40 CFR 721.11090. 
PMN Number: P–17–226 
Chemical name: Manganese(2+), 
bisoctahydro-1,4,7-trimethyl-1H-1,4,7- triazonine- .kappa.N1,.kappa.N4,.kappa.N7)tri- .mu.-oxidi-, hexafluorophosphate(1-) (1:2). 
CAS number: 116633–52–4. 
Effective date of TSCA section 5(e) 
Order: June 15, 2017. 
Basis for TSCA section 5(e) Order: 
The PMN states the generic (non- 
confidential) use of the substance will be as a detergent additive. Based on test data on the substance and analogue test data, EPA has identified concerns for eye irritation, thyroid, blood, and liver toxicity, male reproductive toxicity, neurotoxicity, immunosuppression, respiratory sensitization, and mutagenicity. Based on test data on the substance and test data on analogous neutral organics, EPA identified concern for toxicity to aquatic organisms at surface water concentrations that exceed 240 ppb. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that the substance may present an unreasonable risk of injury to health and the environment. To protect against these risks, the Order requires: 
1. Use of personal protective 
equipment to prevent dermal exposure (where there is a potential for dermal exposure). 
2. Establishment and use of a hazard 
communication program, including human health precautionary statements on each label and in the SDS. 
3. No use other than the confidential 
use allowed in the Order. 
4. No domestic manufacture of the 
substance. 
5. No processing without appropriate 
engineering controls to prevent inhalation exposure, including dust removal with 99.9% efficiency when loading or unloading the substance in powder form. 
6. No release of the substance 
resulting in surface water concentrations that exceed 240 ppb. 
The SNUR would designate as a 
‘‘significant new use’’ the absence of these protective measures. 
Potentially useful information: EPA 
has determined that certain information about the human health toxicity of the PMN substance may be potentially useful to characterize the effects of the PMN substance in support of a request by the PMN submitter to modify the Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that will be designated by this SNUR. EPA has determined that the results of specific target organ toxicity testing of the PMN substance may be potentially useful in characterizing the health effects of the PMN substance. Although the Order does not require this additional testing, the Order’s restrictions on manufacture, processing, distribution in commerce, and use will remain in effect until the Order is modified or revoked by EPA based on submission of this or other information that EPA determines is relevant and needed to evaluate a modification request. 
CFR citation: 40 CFR 721.11091. 
PMN Numbers: P–17–228 and P–17–229 
Chemical names: 2′-Fluoro-4″-alkyl-4- 
propyl-1,1′:4′1″-terphenyl (generic) (P– 
17–228) and 4-ethyl-2′-fluoro-4″-alkyl- 
1,1′:4′1″-terphenyl (generic) (P–17–229). 
CAS numbers: Not available. 
Effective date of TSCA section 5(e) 
Order: May 18, 2017. Basis for TSCA section 5(e) Order: 
The PMN states that the generic (non- 
confidential) use of the substances is a coating for displays. Based on the physical/chemical properties of the substances (as described in the New Chemical Program’s PBT category at 64 FR 60194; November 4, 1999; FRL– 6097–7) and test data on structurally similar substances, the substances are potentially persistent, bioaccumulative, and toxic (PBT) chemicals. EPA estimates that the substances will persist in the environment more than 2 months and estimates a bioaccumulation factor of greater than or equal to 1,000. Further, based on test data on structurally similar chemicals, EPA has identified concerns for reproductive effects, adrenal and liver toxicity. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that the substances may present an unreasonable risk of injury to health and the environment. To protect against these risks, the Order requires: 
1. Use of personal protective 
equipment including impervious gloves to prevent dermal exposure (where there is a potential for dermal exposure). 
2. Establishment and use of a hazard 
communication program, including human health precautionary statements on each label and in the SDS. 
3. No manufacture beyond the 
confidential annual production volume 
limit specified in the Order. 
4. No processing or use of the 
substances in an application method that generates a dust, mist, or aerosol. 
The SNUR would designate as a 
‘‘significant new use’’ the absence of these protective measures. 
Potentially useful information: EPA 
has determined that certain information about the fate and human health toxicity of the PMN substances may be potentially useful to characterize the effects of the PMN substances in support of a request by the PMN submitter to modify the Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that will be designated by this SNUR. EPA has determined that the results of biodegradation and reproductive/ developmental toxicity testing of the PMN substances may be potentially useful in characterizing the health effects of the PMN substances. Although the Order does not require this additional testing, the Order’s restrictions on manufacture, processing, distribution in commerce, use, and disposal will remain in effect until the Order is modified or revoked by EPA based on submission of this or other 
VerDate Sep<11>2014 16:27 Aug 16, 2018 Jkt 244001 PO 00000 Frm 00064 Fmt 4700 Sfmt 4700 E:\FR\FM\17AUR1.SGM 17AUR1daltland on DSKBBV9HB2PROD with RULES40995 Federal Register / Vol. 83, No. 160 / Friday, August 17, 2018 / Rules and Regulations 
information that EPA determines is 
relevant and needed to evaluate a modification request. 
CFR citations: 40 CFR 721.11092 (P– 
17–228) and 40 CFR 721.11093 (P–17– 229). 
PMN Number: P–17–261 
Chemical name: Poly(oxy-1,2- 
ethanediyl),-.alpha.-(2-benzoylbenzoyl)- 
.omega.-[(2-benzoylbenzoyl)oxy]-. 
CAS number: Not available. 
Effective date of TSCA section 5(e) 
Order: June 19, 2017. 
Basis for TSCA section 5(e) Order: 
The PMN states that the substance will 
be used as a difunctional type II photoinitiator for use in inks and coatings. Based on physical/chemical properties, SAR analysis and test data on analogous esters with branched polyols, EPA has identified concerns for corrosion of the skin, eyes, and mucous membranes, developmental toxicity, systemic toxicity, and blood effects. The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that the substance may present an unreasonable risk of injury to health and the environment. EPA’s estimates indicate that variations of the parameters (including batch size, number of processing sites, days per year of operation) of the uses identified for the chemical substance would not result in increased inhalation exposure. To protect against these risks, the Order requires: 
1. Submission of certain toxicity 
testing on the substance prior to exceeding the confidential production volume limit specified in the Order. 
2. Use of personal protective 
equipment including impervious gloves (where there is a potential for dermal exposure). 
3. Establishment and use of a hazard 
communication program, including human health precautionary statements on each label and in the SDS. 
4. No domestic manufacture of the 
substance. 
The SNUR would designate as a 
‘‘significant new use’’ the absence of these protective measures. 
Potentially useful information: EPA 
has determined that certain information about the human health toxicity of the PMN substance may be potentially useful to characterize the effects of the PMN substance in support of a request by the PMN submitter to modify the Order, or if a manufacturer or processor is considering submitting a SNUN for a significant new use that will be designated by this SNUR. The submitter has agreed not to exceed the confidential production limit in the Order without performing irritation testing. 
CFR citation: 40 CFR 721.11094. 
V. Rationale and Objectives of the Rule 
A. Rationale 
During review of the PMNs submitted 
for the chemical substances that are 
subject to these SNURs, EPA concluded that for all 27 chemical substances regulation was warranted under TSCA section 5(e), pending the development of information sufficient to make reasoned evaluations of the health or environmental effects of the chemical substances. The basis for such findings is outlined in Unit IV. Based on these findings, TSCA section 5(e) Orders requiring the use of appropriate exposure controls were negotiated with the PMN submitters. 
The SNURs identify as significant 
new uses any manufacturing, processing, use, distribution in commerce, or disposal that does not conform to the restrictions imposed by the underlying Orders, consistent with TSCA section 5(f)(4). 
B. Objectives 
EPA is issuing these SNURs for 
specific chemical substances which 
have undergone premanufacture review because the Agency wants to achieve the following objectives with regard to the significant new uses designated in this rule: 
•EPA will receive notice of any 
person’s intent to manufacture or process a listed chemical substance for the described significant new use before that activity begins. 
•EPA will have an opportunity to 
review and evaluate data submitted in a SNUN before the notice submitter begins manufacturing or processing a listed chemical substance for the described significant new use. 
•EPA will be able to either determine 
that the prospective manufacture or processing is not likely to present an unreasonable risk, or to take necessary regulatory action associated with any other determination, before the described significant new use of the chemical substance occurs. 
•EPA will identify as significant new 
uses any manufacturing, processing, use, distribution in commerce, or disposal that does not conform to the restrictions imposed by the underlying Orders, consistent with TSCA section 5(f)(4). 
Issuance of a SNUR for a chemical 
substance does not signify that the chemical substance is listed on the TSCA Chemical Substance Inventory (TSCA Inventory). Guidance on how to determine if a chemical substance is on the TSCA Inventory is available on the internet at http://www.epa.gov/opptintr/ existingchemicals/pubs/tscainventory/ index.html. 
VI. Direct Final Procedures 
EPA is issuing these SNURs as direct 
final rules. The effective date of these 
rules is September 17, 2018 without further notice, unless EPA receives written adverse comments before September 17, 2018. 
If EPA receives written adverse 
comments on one or more of these SNURs before September 17, 2018, EPA will withdraw the relevant sections of this direct final rule before its effective date. 
This rule establishes SNURs for a 
number of chemical substances. Any person who submits adverse comments must identify the chemical substance and the new use to which it applies. EPA will not withdraw a SNUR for a chemical substance not identified in the comment. 
VII. Applicability of the Significant 
New Use Designation 
To establish a significant new use, 
EPA must determine that the use is not ongoing. The chemical substances subject to this rule have undergone premanufacture review. In cases where EPA has not received a notice of commencement (NOC) and the chemical substance has not been added to the TSCA Inventory, no person may commence such activities without first submitting a PMN. Therefore, for chemical substances for which an NOC has not been submitted EPA concludes that the designated significant new uses are not ongoing. 
When chemical substances identified 
in this rule are added to the TSCA Inventory, EPA recognizes that, before the rule is effective, other persons might engage in a use that has been identified as a significant new use. However, TSCA section 5(e) Orders have been issued for all of the chemical substances, and the PMN submitters are prohibited by the TSCA section 5(e) Orders from undertaking activities which will be designated as significant new uses. The identities of 13 of the 27 chemical substances subject to this rule have been claimed as confidential and EPA has received no post-PMN bona fide submissions (per §§ 720.25 and 
721.11) for a chemical substance covered by this action. Based on this, the Agency believes that it is highly unlikely that any of the significant new uses described in the regulatory text of this rule are ongoing. 
VerDate Sep<11>2014 16:27 Aug 16, 2018 Jkt 244001 PO 00000 Frm 00065 Fmt 4700 Sfmt 4700 E:\FR\FM\17AUR1.SGM 17AUR1daltland on DSKBBV9HB2PROD with RULES40996 Federal Register / Vol. 83, No. 160 / Friday, August 17, 2018 / Rules and Regulations 
Therefore, EPA designates August 17, 
2018 as the cutoff date for determining 
whether the new use is ongoing. The 
objective of EPA’s approach has been to ensure that a person could not defeat a SNUR by initiating a significant new use before the effective date of the direct final rule. 
Persons who begin commercial 
manufacture or processing of the chemical substances for a significant new use identified as of that date will have to cease any such activity upon the effective date of the final rule. To resume their activities, these persons will have to first comply with all applicable SNUR notification requirements and wait until EPA has conducted a review of the notice, made an appropriate determination on the notice, and has taken such actions as are required with that determination. 
VIII. Development and Submission of 
Information 
EPA recognizes that TSCA section 5 
does not require developing any particular new information (e.g., generating test data) before submission of a SNUN. There is an exception: Development of test data is required where the chemical substance subject to the SNUR is also subject to a rule, order or consent agreement under TSCA section 4 (see TSCA section 5(b)(1)). 
In the absence of a TSCA section 4 
test rule covering the chemical substance, persons are required only to submit information in their possession or control and to describe any other information known to or reasonably ascertainable by them (see 40 CFR 720.50). However, upon review of PMNs and SNUNs, the Agency has the authority to require appropriate testing. Unit IV. lists potentially useful information for all of the listed SNURs. Descriptions of this information are provided for informational purposes. EPA strongly encourages persons, before 
performing any testing, to consult with the Agency pertaining to protocol selection. Furthermore, pursuant to TSCA section 4(h), which pertains to reduction of testing in vertebrate animals, EPA encourages consultation with the Agency on the use of alternative test methods and strategies (also called New Approach Methodologies, or NAMs), if available, to generate the recommended test data. EPA encourages dialog with Agency representatives to help determine how best the submitter can meet both the data needs and the objective of TSCA section 4(h). To access the OCSPP test guidelines referenced in this document electronically, please go to http://www.epa.gov/ocspp and select ‘‘Test Methods and Guidelines.’’ The 
Organisation for Economic Co-operation and Development (OECD) test guidelines are available from the OECD Bookshop at http://www.oecdbookshop.org or SourceOECD at http://
www.sourceoecd.org. 
In certain of the TSCA section 5(e) 
Orders for the chemical substances regulated under this rule, EPA has established production volume limits in view of the lack of data on the potential health and environmental risks that may be posed by the significant new uses or increased exposure to the chemical substances. These limits cannot be exceeded unless the PMN submitter first submits the results of specified tests that would permit a reasoned evaluation of the potential risks posed by these chemical substances. Under recent TSCA section 5(e) Orders, each PMN submitter is required to submit each study at least 14 weeks (earlier TSCA section 5(e) Orders required submissions at least 12 weeks) before reaching the specified production limit. The SNURs contain the same production volume limits as the TSCA section 5(e) Orders. Exceeding these production limits is defined as a significant new use. Persons who intend to exceed the production limit must notify the Agency by submitting a SNUN at least 90 days in advance of commencement of non-exempt commercial manufacture or processing. 
Any request by EPA for the triggered 
and pended testing described in the Orders was made based on EPA’s consideration of available screening- level data, if any, as well as other available information on appropriate testing for the PMN substances. Further, any such testing request on the part of EPA that includes testing on vertebrates was made after consideration of available toxicity information, computational toxicology and bioinformatics, and high-throughput screening methods and their prediction 
models. 
Potentially useful information 
identified in Unit IV. may not be the only means of addressing the potential risks of the chemical substance. However, submitting a SNUN without any test data or other information may increase the likelihood that EPA will take action under TSCA section 5(e), particularly if satisfactory test results have not been obtained from a prior PMN or SNUN submitter. EPA recommends that potential SNUN submitters contact EPA early enough so that they will be able to generate useful information. 
SNUN submitters should be aware 
that EPA will be better able to evaluate SNUNs which provide detailed 
information on the following: 
•Human exposure and 
environmental release that may result from the significant new use of the chemical substances. 
•Information on risks posed by the 
chemical substances compared to risks posed by potential substitutes. 
IX. Procedural Determinations 
By this rule, EPA is establishing 
certain significant new uses which have 
been claimed as CBI subject to Agency confidentiality regulations at 40 CFR part 2 and 40 CFR part 720, subpart E. Absent a final determination or other disposition of the confidentiality claim under 40 CFR part 2 procedures, EPA is required to keep this information confidential. EPA promulgated a procedure to deal with the situation where a specific significant new use is CBI, at § 721.1725(b)(1). 
Under these procedures a 
manufacturer or processor may request EPA to determine whether a proposed use would be a significant new use under the rule. The manufacturer or processor must show that it has a bona fide intent to manufacture or process the 
chemical substance and must identify the specific use for which it intends to manufacture or process the chemical substance. If EPA concludes that the 
person has shown a bona fide intent to manufacture or process the chemical substance, EPA will tell the person whether the use identified in the bona fide submission would be a significant 
new use under the rule. Since most of the chemical identities of the chemical substances subject to these SNURs are also CBI, manufacturers and processors can combine the bona fide submission under the procedure in § 721.1725(b)(1) with that under § 721.11 into a single step. 
If EPA determines that the use 
identified in the bona fide submission would not be a significant new use, i.e., the use does not meet the criteria specified in the rule for a significant new use, that person can manufacture or process the chemical substance so long as the significant new use trigger is not met. In the case of a production volume trigger, this means that the aggregate annual production volume does not exceed that identified in the bona fide submission to EPA. Because of confidentiality concerns, EPA does not typically disclose the actual production volume that constitutes the use trigger. Thus, if the person later intends to exceed that volume, a new bona fide submission would be necessary to determine whether that higher volume would be a significant new use. 
VerDate Sep<11>2014 16:27 Aug 16, 2018 Jkt 244001 PO 00000 Frm 00066 Fmt 4700 Sfmt 4700 E:\FR\FM\17AUR1.SGM 17AUR1daltland on DSKBBV9HB2PROD with RULES40997 Federal Register / Vol. 83, No. 160 / Friday, August 17, 2018 / Rules and Regulations 
X. SNUN Submissions 
According to § 721.1(c), persons 
submitting a SNUN must comply with 
the same notification requirements and EPA regulatory procedures as persons submitting a PMN, including submission of test data on health and environmental effects as described in 40 CFR 720.50. SNUNs must be submitted on EPA Form No. 7710–25, generated using e-PMN software, and submitted to the Agency in accordance with the procedures set forth in 40 CFR 720.40 and 721.25. E-PMN software is available electronically at http://www.epa.gov/ opptintr/newchems. 
XI. Economic Analysis 
EPA has evaluated the potential costs 
of establishing SNUN requirements for 
potential manufacturers and processors of the chemical substances subject to this rule. EPA’s complete economic analysis is available in the docket under docket ID number EPA–HQ–OPPT– 2017–0414. 
XII. Statutory and Executive Order 
Reviews 
A. Executive Order 12866 
This action establishes SNURs for 
several new chemical substances that 
were the subject of PMNs and TSCA section 5(e) Orders. The Office of Management and Budget (OMB) has exempted these types of actions from review under Executive Order 12866, entitled ‘‘Regulatory Planning and Review’’ (58 FR 51735, October 4, 1993). 
B. Paperwork Reduction Act (PRA) 
According to PRA (44 U.S.C. 3501 et 
seq.), an agency may not conduct or 
sponsor, and a person is not required to respond to a collection of information that requires OMB approval under PRA, unless it has been approved by OMB and displays a currently valid OMB control number. The OMB control numbers for EPA’s regulations in title 40 of the CFR, after appearing in the Federal Register, are listed in 40 CFR part 9, and included on the related collection instrument or form, if applicable. EPA is amending the table in 40 CFR part 9 to list the OMB approval number for the information collection requirements contained in this action. This listing of the OMB control numbers and their subsequent codification in the CFR satisfies the display requirements of PRA and OMB’s implementing regulations at 5 CFR part 1320. This Information Collection Request (ICR) was previously subject to public notice and comment prior to OMB approval, and given the technical nature of the table, EPA finds that further notice and comment to amend it is unnecessary. As a result, EPA finds that there is ‘‘good cause’’ under section 553(b)(3)(B) of the Administrative Procedure Act (5 U.S.C. 553(b)(3)(B)) to amend this table without further notice and comment. 
The information collection 
requirements related to this action have already been approved by OMB pursuant to PRA under OMB control number 2070–0012 (EPA ICR No. 574). This action does not impose any burden requiring additional OMB approval. If an entity were to submit a SNUN to the Agency, the annual burden is estimated to average between 30 and 170 hours per response. This burden estimate includes the time needed to review instructions, search existing data sources, gather and maintain the data needed, and complete, review, and submit the required SNUN. 
Send any comments about the 
accuracy of the burden estimate, and any suggested methods for minimizing respondent burden, including through the use of automated collection techniques, to the Director, Collection Strategies Division, Office of Environmental Information (2822T), Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460–0001. Please remember to include the OMB control number in any correspondence, but do not submit any completed forms to this address. 
C. Regulatory Flexibility Act (RFA) 
On February 18, 2012, EPA certified 
pursuant to RFA section 605(b) (5 U.S.C. 
601 et seq.), that promulgation of a 
SNUR does not have a significant economic impact on a substantial number of small entities where the following are true: 
1. A significant number of SNUNs 
would not be submitted by small entities in response to the SNUR. 
2. The SNUR submitted by any small 
entity would not cost significantly more than $8,300. 
A copy of that certification is 
available in the docket for this action. 
This action is within the scope of the 
February 18, 2012 certification. Based on the Economic Analysis discussed in Unit XI. and EPA’s experience promulgating SNURs (discussed in the certification), EPA believes that the following are true: 
•A significant number of SNUNs 
would not be submitted by small entities in response to the SNUR. 
•Submission of the SNUN would not 
cost any small entity significantly more than $8,300. 
Therefore, the promulgation of the 
SNUR would not have a significant economic impact on a substantial number of small entities. 
D. Unfunded Mandates Reform Act 
(UMRA) 
Based on EPA’s experience with 
proposing and finalizing SNURs, State, local, and Tribal governments have not been impacted by these rulemakings, and EPA does not have any reasons to believe that any State, local, or Tribal government will be impacted by this action. As such, EPA has determined that this action does not impose any enforceable duty, contain any unfunded mandate, or otherwise have any effect on small governments subject to the requirements of UMRA sections 202, 203, 204, or 205 (2 U.S.C. 1501 et seq.). 
E. Executive Order 13132 
This action will not have a substantial 
direct effect on States, on the 
relationship between the national government and the States, or on the distribution of power and responsibilities among the various levels of government, as specified in Executive Order 13132, entitled ‘‘Federalism’’ (64 FR 43255, August 10, 1999). 
F. Executive Order 13175 
This action does not have Tribal 
implications because it is not expected 
to have substantial direct effects on Indian Tribes. This action does not significantly nor uniquely affect the communities of Indian Tribal governments, nor does it involve or impose any requirements that affect Indian Tribes. Accordingly, the requirements of Executive Order 13175, entitled ‘‘Consultation and Coordination with Indian Tribal Governments’’ (65 FR 67249, November 9, 2000), do not apply to this action. 
G. Executive Order 13045 
This action is not subject to Executive 
Order 13045, entitled ‘‘Protection of 
Children from Environmental Health Risks and Safety Risks’’ (62 FR 19885, April 23, 1997), because this is not an economically significant regulatory action as defined by Executive Order 12866, and this action does not address environmental health or safety risks disproportionately affecting children. 
H. Executive Order 13211 
This action is not subject to Executive 
Order 13211, entitled ‘‘Actions 
Concerning Regulations That Significantly Affect Energy Supply, Distribution, or Use’’ (66 FR 28355, May 22, 2001), because this action is not expected to affect energy supply, distribution, or use and because this 
VerDate Sep<11>2014 16:27 Aug 16, 2018 Jkt 244001 PO 00000 Frm 00067 Fmt 4700 Sfmt 4700 E:\FR\FM\17AUR1.SGM 17AUR1daltland on DSKBBV9HB2PROD with RULES40998 Federal Register / Vol. 83, No. 160 / Friday, August 17, 2018 / Rules and Regulations 
action is not a significant regulatory 
action under Executive Order 12866. 
I. National Technology Transfer and 
Advancement Act (NTTAA) 
In addition, since this action does not 
involve any technical standards, NTTAA section 12(d) (15 U.S.C. 272 note), does not apply to this action. 
J. Executive Order 12898 
This action does not entail special 
considerations of environmental justice 
related issues as delineated by Executive Order 12898, entitled ‘‘Federal Actions to Address Environmental Justice in Minority Populations and Low-Income Populations’’ (59 FR 7629, February 16, 1994). 
XIII. Congressional Review Act 
Pursuant to the Congressional Review 
Act (5 U.S.C. 801 et seq.), EPA will 
submit a report containing this rule and other required information to the U.S. Senate, the U.S. House of Representatives, and the Comptroller General of the United States prior to publication of the rule in the Federal Register. This action is not a ‘‘major rule’’ as defined by 5 U.S.C. 804(2). 
List of Subjects 40 CFR Part 9 
Environmental protection, Reporting 
and recordkeeping requirements. 40 CFR Part 721 
Environmental protection, Chemicals, 
Hazardous substances, Reporting and 
recordkeeping requirements. 
Dated: August 3, 2018. 
Mark A. Hartman, 
Acting Director, Office of Pollution Prevention 
and Toxics. 
Therefore, 40 CFR parts 9 and 721 are 
amended as follows: 
PART 9—[AMENDED] 
■1. The authority citation for part 9 
continues to read as follows: 
Authority: 7 U.S.C. 135 et seq., 136–136y; 
15 U.S.C. 2001, 2003, 2005, 2006, 2601–2671; 
21 U.S.C. 331j, 346a, 348; 31 U.S.C. 9701; 33 U.S.C. 1251 et seq., 1311, 1313d, 1314, 1318, 
1321, 1326, 1330, 1342, 1344, 1345(d) and (e), 1361; E.O. 11735, 38 FR 21243, 3 CFR, 1971–1975 Comp. p. 973; 42 U.S.C. 241, 242b, 243, 246, 300f, 300g, 300g–1, 300g–2, 300g–3, 300g–4, 300g–5, 300g–6, 300j–1, 300j–2, 300j–3, 300j–4, 300j–9, 1857 et seq., 6901–6992k, 7401–7671q, 7542, 9601–9657, 11023, 11048. 
■2. In § 9.1, add the following sections 
in numerical order under the 
undesignated center heading ‘‘Significant New Uses of Chemical Substances’’ to read as follows: 
§ 9.1 OMB approvals under the Paperwork 
Reduction Act. 
* * * * * 
40 CFR citation OMB 
control No. 
*****  
Significant New Uses of Chemical 
Substances 
*****  
721.11068 ................................... 2070–0012 721.11069 ................................... 2070–0012 721.11070 ................................... 2070–0012 721.11071 ................................... 2070–0012 721.11072 ................................... 2070–0012 721.11073 ................................... 2070–0012 721.11074 ................................... 2070–0012 721.11075 ................................... 2070–0012 721.11076 ................................... 2070–0012 721.11077 ................................... 2070–0012 721.11078 ................................... 2070–0012 721.11079 ................................... 2070–0012 721.11080 ................................... 2070–0012 721.11081 ................................... 2070–0012 721.11082 ................................... 2070–0012 721.11083 ................................... 2070–0012 721.11084 ................................... 2070–0012 721.11085 ................................... 2070–0012 721.11086 ................................... 2070–0012 721.11087 ................................... 2070–0012 721.11088 ................................... 2070–0012 721.11089 ................................... 2070–0012 721.11090 ................................... 2070–0012 721.11091 ................................... 2070–0012 721.11092 ................................... 2070–0012 721.11093 ................................... 2070–0012 721.11094 ................................... 2070–0012 
*****  
* * * * * 
PART 721—[AMENDED] 
■3. The authority citation for part 721 
continues to read as follows: 
Authority: 15 U.S.C. 2604, 2607, and 
2625(c). 
■4. Add § 721.11068 to subpart E to 
read as follows: 
§ 721.11068 Alkanes, C 20–28 , chloro. 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified as alkanes, C
20–28, chloro (PMN P–12–277, 
CAS No. 2097144–43–7) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Industrial, commercial, and 
consumer activities. Requirements as 
specified in § 721.80(k) (flame retardants and plasticizers in polyvinyl chloride, polymers, and rubber; flame retardant, plasticizer, and lubricant in adhesives, caulk, sealants, and coatings; additive in lubricants including metalworking fluids; and flame retardant and waterproofer in textiles). It is a significant new use to manufacture the chemical substance more than 5 years. 
(ii) [Reserved] 
(b) Specific requirements. The 
provisions of subpart A of this part 
apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c) and (i) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
■5. Add § 721.11069 to subpart E to 
read as follows: 
§ 721.11069 Slack waxes (petroleum), 
chloro. 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified as slack waxes (petroleum), chloro (PMN P–12–278, CAS No. 2097144–44–8) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Industrial, commercial, and 
consumer activities. Requirements as 
specified in § 721.80(k) (flame retardants and plasticizers in polyvinyl chloride, polymers, and rubber; flame retardant, plasticizer, and lubricant in adhesives, caulk, sealants, and coatings; additive in lubricants including metalworking fluids; and flame retardant and waterproofer in textiles). It is a significant new use to manufacture the chemical substance more than 5 years. 
(ii) [Reserved] 
(b) Specific requirements. The 
provisions of subpart A of this part 
apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c) and (i) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
■6. Add § 721.11070 to subpart E to 
read as follows: 
VerDate Sep<11>2014 16:27 Aug 16, 2018 Jkt 244001 PO 00000 Frm 00068 Fmt 4700 Sfmt 4700 E:\FR\FM\17AUR1.SGM 17AUR1daltland on DSKBBV9HB2PROD with RULES40999 Federal Register / Vol. 83, No. 160 / Friday, August 17, 2018 / Rules and Regulations 
§ 721.11070 Hexacosane, chloro derivs. 
and octacosane, chloro derivs. 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified as hexacosane, chloro derivs. and octacosane, chloro derivs. (PMN P–12– 280, CAS Nos. 2097144–46–0 and 2097144–47–1) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Industrial, commercial, and 
consumer activities. Requirements as 
specified in § 721.80(k) (flame retardants and plasticizers in polyvinyl chloride, polymers, and rubber; flame retardant, plasticizer, and lubricant in adhesives, caulk, sealants, and coatings; additive in lubricants including metalworking fluids; and flame retardant and waterproofer in textiles). It is a significant new use to manufacture the chemical substance more than 5 years. 
(ii) [Reserved] 
(b) Specific requirements. The 
provisions of subpart A of this part 
apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c) and (i) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
■7. Add § 721.11071 to subpart E to 
read as follows: 
§ 721.11071 Alkanes, C 20–24 , chloro. 
(a) Chemical substance and 
significant new uses subject to reporting. (1) The chemical substance identified as alkanes, C
20–24, chloro (PMN P–12–281, 
CAS No. 2097144–45–9) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Industrial, commercial, and 
consumer activities. Requirements as 
specified in § 721.80(k) (flame retardants and plasticizers in polyvinyl chloride, polymers, and rubber; flame retardant, plasticizer, and lubricant in adhesives, caulk, sealants, and coatings; additive in lubricants including metalworking fluids; and flame retardant and waterproofer in textiles). It is a significant new use to manufacture the chemical substance more than 5 years. 
(ii) [Reserved] 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified 
by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c) and (i) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
■8. Add § 721.11072 to subpart E to 
read as follows: 
§ 721.11072 Alkanes, C 14–16 , chloro. 
(a) Chemical substance and 
significant new uses subject to reporting. (1) The chemical substance identified as alkanes, C
14–16, chloro (PMNs P–12–282 
and P–14–684, CAS No. 1372804–76–6) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Industrial, commercial, and 
consumer activities. Requirements as 
specified in § 721.80(k) (flame retardants and plasticizers in polyvinyl chloride, polymers, and rubber; flame retardant, plasticizer, and lubricant in adhesives, caulk, sealants, and coatings; additive in lubricants including metalworking fluids; and flame retardant and waterproofer in textiles). It is a significant new use to manufacture the chemical substance more than 5 years. 
(ii) [Reserved] 
(b) Specific requirements. The 
provisions of subpart A of this part 
apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c) and (i) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
■9. Add § 721.11073 to subpart E to 
read as follows: 
§ 721.11073 Tetradecane, chloro derivs. 
(a) Chemical substance and 
significant new uses subject to reporting. (1) The chemical substance identified as tetradecane, chloro derivs. (PMNs P–12– 283 and P–14–683, CAS No. 198840– 65–2) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Industrial, commercial, and 
consumer activities. Requirements as 
specified in § 721.80(k) (flame retardants and plasticizers in polyvinyl chloride, polymers, and rubber; flame retardant, plasticizer, and lubricant in adhesives, caulk, sealants, and coatings; additive in lubricants including metalworking fluids; and flame retardant and waterproofer in textiles). It is a significant new use to manufacture the chemical substance more than 5 years. 
(ii) [Reserved] 
(b) Specific requirements. The 
provisions of subpart A of this part 
apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c) and (i) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
■10. Add § 721.11074 to subpart E to 
read as follows: 
§ 721.11074 Octadecane, chloro derivs. 
(a) Chemical substance and 
significant new uses subject to reporting. (1) The chemical substance identified as octadecane, chloro derivs. (PMN P–12– 284, CAS No. 2097144–48–2) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Industrial, commercial, and 
consumer activities. Requirements as 
specified in § 721.80(k) (flame retardants and plasticizers in polyvinyl chloride, polymers, and rubber; flame retardant, plasticizer, and lubricant in adhesives, caulk, sealants, and coatings; additive in lubricants including metalworking fluids; and flame retardant and waterproofer in textiles). It is a significant new use to manufacture the chemical substance more than 5 years. 
(ii) [Reserved] 
(b) Specific requirements. The 
provisions of subpart A of this part 
apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c) and (i) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
■11. Add § 721.11075 to subpart E to 
read as follows: 
§ 721.11075 Alkanes, C 18–20 , chloro. 
(a) Chemical substance and 
significant new uses subject to reporting. 
VerDate Sep<11>2014 16:27 Aug 16, 2018 Jkt 244001 PO 00000 Frm 00069 Fmt 4700 Sfmt 4700 E:\FR\FM\17AUR1.SGM 17AUR1daltland on DSKBBV9HB2PROD with RULES41000 Federal Register / Vol. 83, No. 160 / Friday, August 17, 2018 / Rules and Regulations 
(1) The chemical substance identified as 
alkanes, C 18–20, chloro (PMN P–12–433, 
CAS No. 106262–85–3) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Industrial, commercial, and 
consumer activities. Requirements as 
specified in § 721.80(k) (flame retardants and plasticizers in polyvinyl chloride, polymers, and rubber; flame retardant, plasticizer, and lubricant in adhesives, caulk, sealants, and coatings; additive in lubricants including metalworking fluids; and flame retardant and waterproofer in textiles). It is a significant new use to manufacture the chemical substance more than 5 years. 
(ii) [Reserved] 
(b) Specific requirements. The 
provisions of subpart A of this part 
apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c) and (i) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
■12. Add § 721.11076 to subpart E to 
read as follows: 
§ 721.11076 Alkanes, C 14–17 , chloro. 
(a) Chemical substance and 
significant new uses subject to reporting. (1) The chemical substance identified as alkanes, C
14–17, chloro (PMN P–12–453, 
CAS No. 85535–85–9) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Industrial, commercial, and 
consumer activities. Requirements as 
specified in § 721.80(k) (flame retardants and plasticizers in polyvinyl chloride polymers, and rubber; flame retardant, plasticizer, and lubricant in adhesives, caulk, sealants, and coatings; additive in lubricants including metalworking fluids; and flame retardant and waterproofer in textiles). It is a significant new use to manufacture the chemical substance more than 5 years. 
(ii) [Reserved] 
(b) Specific requirements. The 
provisions of subpart A of this part 
apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c) and (i) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
■13. Add § 721.11077 to subpart E to 
read as follows: 
§ 721.11077 Alkanes, C 22–30 , chloro. 
(a) Chemical substance and 
significant new uses subject to reporting. (1) The chemical substance identified as alkanes, C
22–30, chloro (PMN P–12–505, 
CAS No. 288260–42–4) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Industrial, commercial, and 
consumer activities. Requirements as 
specified in § 721.80(k) (flame retardants and plasticizers in polyvinyl chloride, polymers, and rubber; flame retardant, plasticizer, and lubricant in adhesives, caulk, sealants, and coatings; additive in lubricants including metalworking fluids; and flame retardant and waterproofer in textiles). It is a significant new use to manufacture the chemical substance more than 5 years. 
(ii) [Reserved] 
(b) Specific requirements. The 
provisions of subpart A of this part 
apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c) and (i) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
■14. Add § 721.11078 to subpart E to 
read as follows: 
§ 721.11078 Chloroflurocarbon (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. (1) The chemical substance identified generically as chloroflurocarbon (PMN P–16–150) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (3), and (4), when determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) and (4), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible, (a)(5) (respirators must provide a National Institute for Occupational Safety and Health (NIOSH) assigned protection factor (APF) of at least 1,000), (a)(6) (liquid), and (c). 
(A) As an alternative to the respirator 
requirements in paragraph (a)(2)(i) of this section, a manufacturer or processor may choose to follow the new chemical exposure limit (NCEL) provision listed in the TSCA section 5(e) Order for this substance. The NCEL is 170 ppb as an 8-hour time weighted average. Persons who wish to pursue NCELs as an alternative to § 721.63 respirator requirements may request to do so under § 721.30. Persons whose § 721.30 requests to use the NCELs approach are approved by EPA will be required to follow NCELs provisions comparable to those contained in the corresponding TSCA section 5(e) Order. 
(B) [Reserved] 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) 
through (d), (f), (g)(1) (fatal if inhaled), (g)(2)(ii), (iv), (use respiratory protection or maintain workplace airborne concentrations at or below an 8-hour time-weighted average of 170 ppb), (g)(2)(v), (g)(3)(i), (ii), (g)(4) (release to water restrictions apply), and (g)(5). Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System (GHS) and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(a) through (c), (g), and (q). It is a significant new use to manufacture, process, or use the PMN substance without the engineering controls described in the corresponding TSCA section 5(e) Order to prevent worker and environmental exposures. It is a significant new use to manufacture the chemical substance more than one year. 
(iv) Release to water. Requirements as 
specified in § 721.90(a)(4), (b)(4), and (c)(4) where N = 240. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) and (k) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
VerDate Sep<11>2014 16:27 Aug 16, 2018 Jkt 244001 PO 00000 Frm 00070 Fmt 4700 Sfmt 4700 E:\FR\FM\17AUR1.SGM 17AUR1daltland on DSKBBV9HB2PROD with RULES41001 Federal Register / Vol. 83, No. 160 / Friday, August 17, 2018 / Rules and Regulations 
(3) Determining whether a specific use 
is subject to this section. The provisions 
of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
■15. Add § 721.11079 to subpart E to 
read as follows: 
§ 721.11079 Silane, 1,1′-(1,2- 
ethanediyl)bis[1,1-dichloro-1-methyl]-, hydrolysis products with chloroethenyldimethylsilane. 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified as Silane, 1,1′-(1,2-ethanediyl)bis[1,1- dichloro-1-methyl]-, hydrolysis products with chloroethenyldimethylsilane (PMN P– 16–379, CAS No. 1485477–78–8) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been reacted (cured). 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i), (iv), (a)(3), when determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace 
policies and procedures) shall be considered and implemented to prevent exposure, where feasible, (a)(6)(particulate), (a)(6)(v), (vi), (b) (concentration set at 1.0%), and (c). 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e)(concentration set at 1.0%), (f), (g)(1) (liver toxicity), (mutagenicity), (g)(2)(i), (ii), (iii), (v), (g)(4)(i), (do not incinerate), and (g)(5). Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System (GHS) and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), (q), (y)(1) and (2). 
(iv) Disposal. Requirements as 
specified in § 721.85(a) (water), (a)(2), (b) (water), (b)(2), (c) (water), and (c)(2). 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (j) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
■16. Add § 721.11080 to subpart E to 
read as follows: 
§ 721.11080 Silicophosphonate—sodium 
silicate (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as silicophosphonate— sodium silicate (PMN P–16–410) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Industrial, commercial, and 
consumer activities. Requirements as 
specified in § 721.80(f) and (k). A significant new use is any use in formulations containing greater than 0.2% of the chemical substance. 
(ii) [Reserved] 
(b) Specific requirements. The 
provisions of subpart A of this part 
apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (c) and (i) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(i) of this section. 
■17. Add § 721.11081 to subpart E to 
read as follows: 
§ 721.11081 3-Butenenitrile, 2-(acetyloxy). 
(a) Chemical substance and 
significant new uses subject to reporting. (1) The chemical substance identified as 3-butenenitrile, 2-(acetyloxy) (PMN P– 16–438, CAS No. 15667–63–7) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i), (ii), (iii), (a)(3), (a)(4), when determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) and (4), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible, (a)(5) (respirators must provide a National Institute for Occupational Safety and Health (NIOSH) assigned protection factor (APF) of at least 1000), (a)(6)(particulate), (a)(6)(v), (vi), (b)(concentration set at 1.0%), and (c). It is a significant new use to manufacture, process or use the substance without following the monitoring procedure as specified in the worker protection section of the corresponding TSCA section 5(e) Order. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e)(concentration set at 1.0%), (f), (g)(1) (fatal if swallowed), (fatal if in contact with skin), (toxic if inhaled), (g)(2)(i), (ii), (iii), (iv), (v), (g)(3)(i), (ii), (g)(4)(i), (ii), (iii), and (g)(5). Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System (GHS) and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(g). It is a significant new use to manufacture or use the substance other than in an enclosed system as described in the PMN. 
(iv) Release to water. Requirements as 
specified in § 721.90(a)(1), (b)(1), and (c)(1). 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) and (k) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
■18. Add § 721.11082 to subpart E to 
read as follows: 
§ 721.11082 Halogenophosphoric acid 
metal salt (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as halogenophosphoric acid metal salt (PMN P–16–543) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
VerDate Sep<11>2014 16:27 Aug 16, 2018 Jkt 244001 PO 00000 Frm 00071 Fmt 4700 Sfmt 4700 E:\FR\FM\17AUR1.SGM 17AUR1daltland on DSKBBV9HB2PROD with RULES41002 Federal Register / Vol. 83, No. 160 / Friday, August 17, 2018 / Rules and Regulations 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(the confidential dermal protection described in the corresponding TSCA section 5(e) Order ‘‘the Order’’), (a)(2)(ii), (iii), (iv), (a)(3), (a)(4), when determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) and (4), engineering control measures (e.g., enclosure or confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible, (a)(5) (respirators must provide a National Institute for Occupational Safety and Health (NIOSH) assigned protection factor of at least 1,000), (a)(6) (particulate), (a)(6)(v), (vi), (b)(concentration set at 0.1%), and (c). It is a significant new use to manufacture, process or use the substance without following the monitoring procedure as specified in the worker protection section of the Order. 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e) (concentration set at 0.1%), (f), (g)(1)(i), (ii), (iii), (iv), (v), (vii), (viii), (ix), (g)(2)(i), (ii), (iii), (use protective engineering controls or equipment for dermal and inhalation protection, (g)(3)(i), (ii), (g)(4)(i), (ii), (water release restrictions apply), and (g)(5). Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System (GHS) and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as 
specified in § 721.80(c), (f), and (k). It is a significant new use to vary or alter, the manufacturing, processing, and use, distribution/transportation, treatment and disposal processes, process equipment, engineering controls, and handling practices (including worker activities and cleaning procedures) described in the PMN in such a way as to increase the magnitude of inhalation exposure. 
(iv) Disposal. Requirements as 
specified in § 721.85. It is a significant new use to dispose of the substance other than by hazardous waste incineration according to 40 CFR parts 260 through 299 unless the substance is in waste water. When the substance is in wastewater it may be disposed of as required in paragraph (a)(2)(v) of this section. 
(v) Release to water. Requirements as 
specified in § 721.90(a)(4), (b)(4), and (c)(4) where N=3. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (k) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraphs (a)(2)(i) and (iii) of this section. 
■19. Add § 721.11083 to subpart E to 
read as follows: 
§ 721.11083 Alkenoic acid, reaction 
products with polyethylene glycol ether with hydroxyalkyl substituted alkane (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as alkenoic acid, reaction products with polyethylene glycol ether with hydroxyalkyl substituted alkane (PMN P–16–596) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been reacted (cured). 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i), (a)(3), when determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace 
policies and procedures) shall be considered and implemented to prevent exposure, where feasible, (b) (concentration set at 0.1%), and (c). 
(ii) Hazard communication. 
Requirements as specified in § 721.72 (a) through (e)(concentration set at 0.1%), (f), (g)(1)(i), (dermal sensitization), (g)(1)(iv), (cancer, if inhaled), (g)(1)(ix), (g)(2)(i), (ii), (iii), (v), (g)(4)(iii), and (g)(5). Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System (GHS) and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), and (q). 
(iv) Release to water. Requirements as 
specified in § 721.90(a)(1), (b)(1), and (c)(1). 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) and (k) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
■20. Add § 721.11084 to subpart E to 
read as follows: 
§ 721.11084 Alkyl substituted alkenoic 
acid, alkyl ester, polymer with alkyl substituted alkenoate and alkenoic acid, hydroxy substituted[(oxoalkyl)oxy]alkyl ester, reaction products with alkanoic acid, dipentaerythritil and isocyanate substituted carbomonocycle, compds. with alkylamine (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as alkyl substituted alkenoic acid, alkyl ester, polymer with alkyl substituted alkenoate and alkenoic acid, hydroxy substituted[(oxoalkyl)oxy]alkyl ester, reaction products with alkanoic acid, dipentaerythritil and isocyanate substituted carbomonocycle, compds. with alkylamine (PMN P–17–10) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been reacted (cured). 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i), (a)(3), when determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1), engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace 
policies and procedures) shall be considered and implemented to prevent exposure, where feasible, (a)(6)(particulate), (a)(6)(v), (vi), (b) (concentration set at 0.1%), and (c). 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e) (concentration set at 0.1%), (f), (g)(1)(i), (sensitization), (g)(1)(vii), (systemic effects), (g)(1)(ix), (g)(2)(i), (ii), (iii), (v), and (g)(5). Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System (GHS) and OSHA Hazard Communication Standard may be used. 
VerDate Sep<11>2014 16:27 Aug 16, 2018 Jkt 244001 PO 00000 Frm 00072 Fmt 4700 Sfmt 4700 E:\FR\FM\17AUR1.SGM 17AUR1daltland on DSKBBV9HB2PROD with RULES41003 Federal Register / Vol. 83, No. 160 / Friday, August 17, 2018 / Rules and Regulations 
(iii) Industrial, commercial, and 
consumer activities. Requirements as 
specified in § 721.80(f), (k) (ultraviolet curable coating resin), and (y)(1). It is a significant new use to manufacture the chemical substance with an average molecular weight below 2,000 daltons or containing greater than 0.1% residual isocyanate. It is a significant new use to import the substance other than in totes. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
■21. Add § 721.11085 to subpart E to 
read as follows: 
§ 721.11085 Heteromonocycle ester with 
alkanediol (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as heteromonocycle ester with alkanediol (PMN P–17–15) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been reacted (cured). 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i), (iii), (iv), (a)(3), when determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace 
policies and procedures) shall be considered and implemented to prevent exposure, where feasible, (b) (concentration set at 1.0%), and (c). 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e) (concentration set at 1.0%), (f), (g)(1)(i), (g)(2)(i), (ii), (iii), (v), (g)(3)(i), (ii), (g)(4) (release to water restrictions apply), and (g)(5). Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System (GHS) and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), and (q). (iv) Release to water. Requirements as 
specified in § 721.90(a)(4), (b)(4), and (c)(4) where N=3. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) and (k) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
■22. Add § 721.11086 to subpart E to 
read as follows: 
§ 721.11086 Substituted carbomonocycle, 
polymer with (aminoalkyl)-alkanediamine, (haloalkyl)oxirane, dialkyl-alkanediamine and alkyl-alkanamine, reaction products with dialkanolamine and [[(alkyl)oxy]alkyl]oxirane (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as substituted carbomonocycle, polymer with (aminoalkyl)-alkanediamine, (haloalkyl)oxirane, dialkyl- alkanediamine and alkyl-alkanamine, reaction products with dialkanolamine and [[(alkyl)oxy]alkyl]oxirane (PMN P– 17–29) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been reacted (cured). 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i), (ii), (iii), (a)(3), when determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace 
policies and procedures) shall be considered and implemented to prevent exposure, where feasible, (b) (concentration set at 1.0%), and (c). 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e) (concentration set at 1.0%), (f), (g)(1)(i), (eye irritation), (g)(1)(ii), (g)(2)(i), (ii), (iii), (v), (g)(3)(i), (ii), (g)(4)(iii), and (g)(5). Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System (GHS) and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f), (k), (q), and (y)(1). 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
■23. Add § 721.11087 to subpart E to 
read as follows: 
§ 721.11087 Carboxylic acid amine (1:1) 
(generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as carboxylic acid amine (1:1) (PMN P–17–154) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been reacted (cured). 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i), (ii), (iv), (a)(3), when determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace 
policies and procedures) shall be considered and implemented to prevent exposure, where feasible, (a)(6) (particulate), (a)(6)(v), (vi), (b) (concentration set at 1.0%), and (c). 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e) (concentration set at 1.0%), (f), (g)(1)(i), (ii), (iii), (thyroid effects), (g)(1)(vi), (ix), (g)(2)(i), (ii), (iii), (v), (g)(3)(i), (ii), and (g)(5). Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System (GHS) and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(q). 
VerDate Sep<11>2014 16:27 Aug 16, 2018 Jkt 244001 PO 00000 Frm 00073 Fmt 4700 Sfmt 4700 E:\FR\FM\17AUR1.SGM 17AUR1daltland on DSKBBV9HB2PROD with RULES41004 Federal Register / Vol. 83, No. 160 / Friday, August 17, 2018 / Rules and Regulations 
(b) Specific requirements. The 
provisions of subpart A of this part 
apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
■24. Add § 721.11088 to subpart E to 
read as follows: 
§ 721.11088 Mix fatty acids compd with 
amine (1:1) (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as mix fatty acids compd with amine (1:1) (PMN P–17–155) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the PMN substance after they have been reacted (cured). 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i), (ii), (iv), (a)(3), when determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace 
policies and procedures) shall be considered and implemented to prevent exposure, where feasible, (a)(6) (particulate), (a)(6)(v), (vi), (b) (concentration set at 1.0%), and (c). 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e)(concentration set at 1.0%), (f), (g)(1)(i), (ii), (iii), (thyroid effects), (g)(1)(vi), (ix), (g)(2)(i), (ii), (iii), (v), (g)(3)(i), (ii), and (g)(5). Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System (GHS) and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(q). 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). (1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
■25. Add § 721.11089 to subpart E to 
read as follows: 
§ 721.11089 Mix fatty acids compd with 
amine (1:1) (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as mix fatty acids compd with amine (1:1) (PMN P–17–156) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been reacted (cured). 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i), (iii), (iv), (a)(3), when determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace 
policies and procedures) shall be considered and implemented to prevent exposure, where feasible, (a)(6) (particulate), (a)(6)(v), (vi), (b) (concentration set a 1.0%), and (c). 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e)(concentration set at 1.0%), (f), (g)(1)(i), (ii), (iii), (thyroid effects), (g)(1)(vi), (ix), (g)(2)(i), (ii), (iii), (v), (g)(3)(i), (ii), and (g)(5). Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System (GHS) and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(q). 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. (2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
■26. Add § 721.11090 to subpart E to 
read as follows: 
§ 721.11090 Bicyclo[2.2.1]heptane-1- 
methanesulfonic acid, 7,7-dimethyl-2-oxo-, compd. with N,N-diethylethanamine (1:1). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified as bicyclo[2.2.1]heptane-1- methanesulfonic acid, 7,7-dimethyl-2- oxo-, compd. with N,N- diethylethanamine (1:1) (PMN P–17– 218. CAS No. 67019–84–5) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i), (a)(3), when determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace 
policies and procedures) shall be considered and implemented to prevent exposure, where feasible, (a)(6) (particulate), (a)(6)(v), (vi), (b) (concentration set 1.0%), and (c). 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e) (concentration set at 1.0%), (f), (g)(1)(i), (corrosivity), (sensitization), (g)(1)(iii), (iv), (ix), (g)(2)(i), (ii), (iii), (v), and (g)(5). Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System (GHS) and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(q), (y)(1) and (2). 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions 
VerDate Sep<11>2014 16:27 Aug 16, 2018 Jkt 244001 PO 00000 Frm 00074 Fmt 4700 Sfmt 4700 E:\FR\FM\17AUR1.SGM 17AUR1daltland on DSKBBV9HB2PROD with RULES41005 Federal Register / Vol. 83, No. 160 / Friday, August 17, 2018 / Rules and Regulations 
of § 721.1725(b)(1) apply to paragraph 
(a)(2)(iii) of this section. 
■27. Add § 721.11091 to subpart E to 
read as follows: 
§ 721.11091 Manganese (2+), 
bisoctahydro-1,4,7-trimethyl-1H–1,4,7- triazonine-.kappa.N1,.kappa.N4,.kappa.N7) tri-.mu.-oxidi-, hexafluorophosphate(1-) (1:2). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified as manganese (2+), bisoctahydro-1,4,7- trimethyl-1H–1,4,7-triazonine- .kappa.N1,.kappa.N4,.kappa.N7) tri- .mu.-oxidi-, hexafluorophosphate(1-) (1:2) (1:1) (PMN P–17–226, CAS No. 116633–52–4) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i), (ii), (iii), (a)(3), when determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace 
policies and procedures) shall be considered and implemented to prevent exposure, where feasible, (a)(6) (particulate), (b) (concentration set at 0.1%), and (c). 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e) (concentration set at 0.1%), (f), (g)(1) (eye irritation), (respiratory sensitization), (g)(1)(iii), (iv), (vi), (vii), (viii), (g)(2)(i), (ii), (iii), (v), (g)(3)(i), (ii), (g)(4) (release to water provisions apply), and (g)(5). Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System (GHS) and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f) and (k). It is a significant new use to process or use the substance without engineering controls to prevent exposure, including dust removal with 99.9% efficiency when loading or unloading the substance in powder form. 
(iv) Release to water. Requirements as 
specified in § 721.90(a)(4), (b)(4), and (c)(4) where N=240. 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) and (k) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
■28. Add § 721.11092 subpart E to read 
as follows: 
§ 721.11092 2′-Fluoro-4″-alkyl-4-propyl- 
1,1′:4′1″-terphenyl (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as 2′-fluoro-4″-alkyl-4- propyl-1,1′:4′1″-terphenyl (PMN P–17– 
228) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i), (a)(3), when determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace 
policies and procedures) shall be considered and implemented to prevent exposure, where feasible, (b) (concentration set at 1.0%), and (c). 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e)(concentration set at 1.0%), (f), (g)(1)(vi), (adrenal effects), (liver effects), (g)(2)(i), (ii), (iii), (v), and (g)(5). Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System (GHS) and OSHA Hazard Communication Standard may be used. 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(t) and (y)(1). 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. ■29. Add § 721.11093 to subpart E to 
read as follows: 
§ 721.11093 4-ethyl-2′-fluoro-4″-alkyl- 
1,1′:4′,1″-terphenyl (generic). 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified generically as 4-ethyl-2′-fluoro-4″-alkyl- 
1,1′:4′,1″-terphenyl (PMN P–17–229) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i), (a)(3), when determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace 
policies and procedures) shall be considered and implemented to prevent exposure, where feasible, (b) (concentration set 1.0%), and (c). 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e) (concentration set 1.0%), (f), (g)(1)(vi), (adrenal effects), (liver effects), (g)(2)(i), (ii), (iii), (v), and (g)(5). 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(t) and (y)(1). 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
■30. Add § 721.11094 to subpart E to 
read as follows: 
§ 721.11094 Poly(oxy-1,2- 
ethanediyl),alpha-(2-benzoyl)-omega-[(2- benzoylbenzoyl)oxy]-. 
(a) Chemical substance and 
significant new uses subject to reporting. 
(1) The chemical substance identified as poly(oxy-1,2-ethanediyl),alpha-(2- benzoyl)-omega-[(2- benzoylbenzoyl)oxy]- (PMN P–17–261) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not 
VerDate Sep<11>2014 16:27 Aug 16, 2018 Jkt 244001 PO 00000 Frm 00075 Fmt 4700 Sfmt 4700 E:\FR\FM\17AUR1.SGM 17AUR1daltland on DSKBBV9HB2PROD with RULES41006 Federal Register / Vol. 83, No. 160 / Friday, August 17, 2018 / Rules and Regulations 
1The SJVUAPCD adopted its 2014 RACT SIP on 
June 19, 2014. 
2CARB’s May 4, 2018 transmittal letter contained 
a public draft version of the Supplement to the 2014 
RACT SIP along with a request that the EPA provide parallel processing of the documents concurrently with the state’s public process. See footnote 1 in our May 17, 2018 proposed rule. 
3See Supplement to the 2014 RACT SIP, 
Appendix B. 
4On June 21, 2018, the SJVUAPCD Governing 
Board adopted ‘‘Revision to the State Implementation Plan (SIP) to Address Federal Clean Air Act Requirements for Reasonably Available Control Technology (RACT)’’. Appendix A: ‘‘J.R. Simplot Permit Conditions’’ and Appendix B: ‘‘Negative Declarations’’, as contained in the adopted document, are substantially similar to the versions contained in the District’s parallel processing request which the EPA proposed to apply to quantities of the substance after 
they have been reacted (cured). 
(2) The significant new uses are: 
(i) Protection in the workplace. 
Requirements as specified in 
§ 721.63(a)(1), (a)(2)(i), (a)(3), when determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) engineering control measures (e.g., enclosure or 
confinement of the operation, general and local ventilation) or administrative control measures (e.g., workplace 
policies and procedures) shall be considered and implemented to prevent exposure, where feasible, (b) (concentration set at 1.0%), and (c). 
(ii) Hazard communication. 
Requirements as specified in § 721.72(a) through (e) (concentration set at 1.0%), (f), (g)(1) (irritation), (photosensitization), (g)(2)(i), (ii), (iii), (v), and (g)(5). 
(iii) Industrial, commercial, and 
consumer activities. Requirements as specified in § 721.80(f) and (q). 
(b) Specific requirements. The 
provisions of subpart A of this part apply to this section except as modified by this paragraph (b). 
(1) Recordkeeping. Recordkeeping 
requirements as specified in § 721.125(a) through (i) are applicable to manufacturers and processors of this substance. 
(2) Limitations or revocation of 
certain notification requirements. The provisions of § 721.185 apply to this section. 
(3) Determining whether a specific use 
is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section. 
[FR Doc. 2018–17348 Filed 8–16–18; 8:45 am] 
BILLING CODE 6560–50–P 
ENVIRONMENTAL PROTECTION AGENCY 
40 CFR Part 52 
[EPA–R09–OAR–2018–0272; FRL–9981–09– 
Region 9] 
Air Plan Approval; California; San 
Joaquin Valley Unified Air Pollution Control District; Reasonably Available Control Technology Demonstration 
AGENCY : Environmental Protection 
Agency (EPA). 
ACTION : Final rule. 
SUMMARY : The Environmental Protection 
Agency (EPA) is taking final action to approve revisions to the San Joaquin Valley Unified Air Pollution Control District (SJVUAPCD or ‘‘District’’) portion of the California State Implementation Plan (SIP). These revisions concern the District’s 2014 demonstration regarding Reasonably Available Control Technology (RACT) requirements for the 2008 8-hour ozone National Ambient Air Quality Standard (NAAQS). We are also taking final action to approve into the California SIP the following documents that help support the District’s RACT demonstration: SJVUAPCD’s supplement to its 2014 RACT SIP demonstration, which contains SJVUAPCD’s negative declarations where the District concludes it has no sources subject to certain Control Techniques Guidelines (CTG) documents and relevant permit conditions to implement RACT level requirements for J.R. Simplot’s Nitric Acid plant in Helm, California (CA); and SJVUAPCD’s 2016 Ozone Plan for the 2008 8-Hour Ozone Standard—Chapter 3.4 and Appendix C only. We are approving local SIP revisions to demonstrate that RACT is implemented as required under the Clean Air Act (CAA or the ‘‘the Act’’). 
DATES : This rule will be effective on 
September 17, 2018. 
ADDRESSES : The EPA has established a 
docket for this action under Docket ID No. EPA–R09–OAR–2018–0272. All documents in the docket are listed on the https://www.regulations.gov 
website. Although listed in the index, some information is not publicly available, e.g., Confidential Business 
Information or other information whose disclosure is restricted by statute. Certain other material, such as copyrighted material, is not placed on the internet and will be publicly available only in hard copy form. Publicly available docket materials are available through https://www.regulations.gov, or please contact 
the person identified in the 
FOR FURTHER  
INFORMATION CONTACT section for 
additional availability information. 
FOR FURTHER INFORMATION CONTACT : 
Stanley Tong, EPA Region IX, (415) 947–4122, tong.stanley@epa.gov. 
SUPPLEMENTARY INFORMATION : 
Throughout this document, ‘‘we,’’ ‘‘us’’ and ‘‘our’’ refer to the EPA. 
Table of Contents 
I. Proposed Action 
II. Public Comments and EPA Responses III. EPA Action IV. Incorporation by Reference V. Statutory and Executive Order Reviews 
I. Proposed Action 
On May 17, 2018 (83 FR 22908), the 
EPA proposed to approve SJVUACPD’s 
‘‘2014 Reasonably Available Control Technology (RACT) Demonstration for 
the 8-Hour Ozone State Implementation Plan (SIP)’’ (2014 RACT SIP), submitted to the EPA by the California Air Resources Board (CARB) on July 18, 2014,
1for approval as a revision to the 
California SIP. 
In addition to the 2014 RACT SIP, our 
May 17, 2018 proposed rule was also based on our evaluation of the public draft version of SJVUAPCD’s ‘‘Supplement to the 2014 Reasonably Available Control Technology (RACT) State Implementation Plan (SIP) for the 
2008 8-hour Ozone Standard’’ (Supplement to the 2014 RACT SIP) that 
was transmitted by CARB on May 4, 2018, along with a request for parallel processing.
2The District’s Supplement 
to the 2014 RACT SIP contained relevant RACT permit conditions in a permit to operate for J.R. Simplot’s Nitric Acid plant in Helm, CA, and negative declarations where the District concluded it had no sources subject to the following CTG source categories: Surface coating of insulation of magnetic wire; manufacture of synthesized pharmaceutical products; manufacture of pneumatic rubber tires; leaks from synthetic organic chemical polymer and resin manufacturing equipment; volatile organic compound (VOC) emissions from manufacture of high-density polyethylene, polypropylene and polyester resins; VOC emissions from air oxidation processes in synthetic organic chemical manufacturing industry (SOCMI); VOC emissions from reactor processes and distillation operations in SOCMI; and surface coating operations at shipbuilding and ship repair facilities.
3 
We indicated that we would not take final action on the Supplement to the 2014 RACT SIP until CARB submitted the final adopted version to the EPA as a SIP revision. On June 21, 2018, the SJVUAPCD held a public hearing and adopted the Supplement to the 2014 RACT SIP.
4On June 29, 2018, CARB 
VerDate Sep<11>2014 16:27 Aug 16, 2018 Jkt 244001 PO 00000 Frm 00076 Fmt 4700 Sfmt 4700 E:\FR\FM\17AUR1.SGM 17AUR1daltland on DSKBBV9HB2PROD with RULES